-
1
-
-
0036345808
-
Host-microbe interactions: Fungi invasive human fungal opportunistic infections
-
Latgé, J.P.; Calderone, R. Host-microbe interactions: fungi invasive human fungal opportunistic infections. Curr. Opin. Microbiol., 2002, 5, 355-358.
-
(2002)
Curr. Opin. Microbiol.
, vol.5
, pp. 355-358
-
-
Latgé, J.P.1
Calderone, R.2
-
2
-
-
35748930059
-
Recent trends in the epidemiology of invasive mycoses
-
Clark, T.A.; Hajjeh, R.A. Recent trends in the epidemiology of invasive mycoses. Curr. Opin. Infect. Dis., 2004, 17, 511-515.
-
(2004)
Curr. Opin. Infect. Dis.
, vol.17
, pp. 511-515
-
-
Clark, T.A.1
Hajjeh, R.A.2
-
3
-
-
33746894800
-
The changing epidemiology of invasive fungal infections: new threats
-
DOI 10.1016/j.ijantimicag.2006.03.006, PII S0924857906000793
-
Maschmeyer, G. The changing epidemiology of invasive fungal infections: new threats. Int. J. Antimicrob. Agents, 2006, 27, 3-6. (Pubitemid 44218692)
-
(2006)
International Journal of Antimicrobial Agents
, vol.27
, Issue.SUPPL. 1
, pp. 3-6
-
-
Maschmeyer, G.1
-
4
-
-
33746046039
-
Invasive fungal pathogens: Current epidemiological trends
-
DOI 10.1086/504490
-
Pfaller, M.A.; Pappas, P.G.; Wingard, J.R. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis., 2006, 43, S3-S14. (Pubitemid 44078892)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.SUPPL. 1
-
-
Pfaller, M.A.1
Pappas, P.G.2
Wingard, J.R.3
-
5
-
-
55649109052
-
Epidemiology of invasive fungal infection
-
Castón-Osorio, J.J.; Rivero, A.; Torre-Cisneros, J. Epidemiology of invasive fungal infection. Int. J. Antimicrob. Agents, 2008, 32, S103-S109.
-
(2008)
Int. J. Antimicrob. Agents
, vol.32
-
-
Castón-Osorio, J.J.1
Rivero, A.2
Torre-Cisneros, J.3
-
7
-
-
77950293002
-
Invasive fungal infections in the ICU
-
Shoham, S.; Marwaha, S. Invasive fungal infections in the ICU. J. Intensive Care Med., 2010, 25, 78-92.
-
(2010)
J. Intensive Care Med.
, vol.25
, pp. 78-92
-
-
Shoham, S.1
Marwaha, S.2
-
8
-
-
0037451929
-
The epidemiology of sepsis in the United States from 1979 through 2000
-
DOI 10.1056/NEJMoa022139
-
Martin, G.S.; Mannino, D.M.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 2003, 348, 1546-1554. (Pubitemid 36437931)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.16
, pp. 1546-1554
-
-
Martin, G.S.1
Mannino, D.M.2
Eaton, S.3
Moss, M.4
-
9
-
-
0029959130
-
Epidemiology of nosocomial fungal infections
-
Fridkin, S.K.; Jarvis, W.R. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev., 1996, 9, 499-511. (Pubitemid 26366535)
-
(1996)
Clinical Microbiology Reviews
, vol.9
, Issue.4
, pp. 499-511
-
-
Fridkin, S.K.1
Jarvis, W.R.2
-
10
-
-
0036449514
-
Candidemia at a tertiary-care hospital: Epidemiology, treatment, clinical outcome and risk factors for death
-
DOI 10.1007/s10096-002-0822-1
-
Viudes, A.; Pemán, J.; Cantón, E.; Ubeda, P.; López-Ribot, J.L.; Gobernado, M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis., 2002, 21, 767-774. (Pubitemid 35435697)
-
(2002)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.21
, Issue.11
, pp. 767-774
-
-
Viudes, A.1
Peman, J.2
Canton, E.3
Ubeda, P.4
Lopez-Ribot, J.L.5
Gobernado, M.6
-
11
-
-
33644875309
-
Empirical anti-Candida therapy among selected patients in the intensive care unit: A cost-effectiveness analysis
-
Golan, Y.; Wolf, M.P.; Pauker, S.G.; Wong, J.B.; Hadley, S. Empirical anti- Candida therapy among selected patients in the intensive care unit: a costeffectiveness analysis. Ann. Intern. Med., 2005, 143, 857-869. (Pubitemid 46202221)
-
(2005)
Annals of Internal Medicine
, vol.143
, Issue.12
, pp. 857-869
-
-
Golan, Y.1
Wolf, M.P.2
Pauker, S.G.3
Wong, J.B.4
Hadley, S.5
-
12
-
-
67649537728
-
Candida albicans and non-albicans bloodstream infections in adult andpediatric patients: Comparison of mortality and costs
-
Moran, C.; Grussemeyer, C.A.; Spalding, J.R.; Benjamin, D.K.; Reed, S.D. Candida albicans and non-albicans bloodstream infections in adult andpediatric patients: comparison of mortality and costs. Pediatr. Infect. Dis. J., 2009, 28, 433-435.
-
(2009)
Pediatr. Infect. Dis. J.
, vol.28
, pp. 433-435
-
-
Moran, C.1
Grussemeyer, C.A.2
Spalding, J.R.3
Benjamin, D.K.4
Reed, S.D.5
-
13
-
-
74449092600
-
Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections
-
Moran, C.; Grussemeyer, C.A.; Spalding, J.R.; Benjamin, D.K.; Reed, S.D. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am. J. Infect. Control, 2010, 38, 78-80.
-
(2010)
Am. J. Infect. Control
, vol.38
, pp. 78-80
-
-
Moran, C.1
Grussemeyer, C.A.2
Spalding, J.R.3
Benjamin, D.K.4
Reed, S.D.5
-
14
-
-
0036174370
-
The direct cost and incidence of systemic fungal infections
-
DOI 10.1046/j.1524-4733.2002.51108.x
-
Wilson, L.S.; Reyes, C.M.; Stolpman, M.; Speckman, J.; Allen, K.; Beney, J. The direct cost and incidence of systemic fungal infections. Value Health, 2002, 5, 26-34. (Pubitemid 34160368)
-
(2002)
Value in Health
, vol.5
, Issue.1
, pp. 26-34
-
-
Wilson, L.S.1
Reyes, C.M.2
Stolpman, M.3
Speckman, J.4
Allen, K.5
Beney, J.6
-
15
-
-
40349110978
-
Update on new antifungal therapy
-
Juang, P. Update on new antifungal therapy. AACN. Adv. Crit. Care, 2007, 18, 253-260.
-
(2007)
AACN. Adv. Crit. Care
, vol.18
, pp. 253-260
-
-
Juang, P.1
-
16
-
-
43049141529
-
Current challenges in the management of invasive fungal infections
-
Lai, C.C.; Tan, C.K.; Huang, Y.T.; Shao, P.L.; Hsueh, P.R. Current challenges in the management of invasive fungal infections. J. Infect. Chemother., 2008, 14, 77-85.
-
(2008)
J. Infect. Chemother.
, vol.14
, pp. 77-85
-
-
Lai, C.C.1
Tan, C.K.2
Huang, Y.T.3
Shao, P.L.4
Hsueh, P.R.5
-
17
-
-
0036792188
-
Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility
-
Pfaller, M.A.; Diekema, D.J. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol., 2007, 40, 3551-3557.
-
(2007)
J. Clin. Microbiol.
, vol.40
, pp. 3551-3557
-
-
Pfaller, M.A.1
Diekema, D.J.2
-
18
-
-
33846466508
-
Epidemiology of invasive candidiasis: A persistent public health problem
-
DOI 10.1128/CMR.00029-06
-
Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 2007, 20, 133-163. (Pubitemid 46167771)
-
(2007)
Clinical Microbiology Reviews
, vol.20
, Issue.1
, pp. 133-163
-
-
Pfaller, M.A.1
Diekema, D.J.2
-
19
-
-
77950215343
-
Candidosis a new challenge
-
López-Martínez, R. Candidosis a new challenge. Clin. Dermatol., 2010, 28, 178-184.
-
(2010)
Clin. Dermatol.
, vol.28
, pp. 178-184
-
-
López-Martínez, R.1
-
20
-
-
78449292335
-
Pathogenesis of invasive candidiasis
-
van de Veerdonk, F.L.; Kullberg, B.J.; Netea, M.G. Pathogenesis of invasive candidiasis. Curr. Opin. Crit. Care, 2010, 16, 453-459.
-
(2010)
Curr. Opin. Crit. Care
, vol.16
, pp. 453-459
-
-
Van De Veerdonk, F.L.1
Kullberg, B.J.2
Netea, M.G.3
-
21
-
-
3943093972
-
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
-
DOI 10.1086/421946
-
Wisplinghoff, H.; Bischoff, T.; Tallent, S.M.; Seifert, H.; Wenzel, R.P.; Edmond, M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 2004, 39, 309-317. (Pubitemid 39050477)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.3
, pp. 309-317
-
-
Wisplinghoff, H.1
Bischoff, T.2
Tallent, S.M.3
Seifert, H.4
Wenzel, R.P.5
Edmond, M.B.6
-
22
-
-
0033503937
-
The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance
-
DOI 10.1086/313450
-
Kao, A.S.; Brandt, M.E.; Pruitt, W.R.; Conn, L.A.; Perkins, B.A.; Stephens, D.S.; Baughman, W.S.; Reingold, A.L.; Rothrock, G.A.; Pfaller, M.A.; Pinner, R.W.; Hajjeh, R.A. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis., 1999, 29, 1164-1170. (Pubitemid 30265634)
-
(1999)
Clinical Infectious Diseases
, vol.29
, Issue.5
, pp. 1164-1170
-
-
Kao, A.S.1
Brandt, M.E.2
Pruitt, W.R.3
Conn, L.A.4
Perkins, B.A.5
Stephens, D.S.6
Baughman, W.S.7
Reingold, A.L.8
Rothrock, G.A.9
Pfaller, M.A.10
Pinner, R.W.11
Hajjeh, R.A.12
-
23
-
-
0036204095
-
Epidemiology of candidemia: 3-Year results from the emerging infections and the epidemiology of Iowa organisms study
-
DOI 10.1128/JCM.40.4.1298-1302.2002
-
Diekema, D.J.; Messer, S.A.; Brueggemann, A.B.; Coffman, S.L.; Doern, G.V.; Herwaldt, L.A.; Pfaller, M.A. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J. Clin. Microbiol., 2002, 40, 1298-1302. (Pubitemid 34279892)
-
(2002)
Journal of Clinical Microbiology
, vol.40
, Issue.4
, pp. 1298-1302
-
-
Diekema, D.J.1
Messer, S.A.2
Brueggemann, A.B.3
Coffman, S.L.4
Doern, G.V.5
Herwaldt, L.A.6
Pfaller, M.A.7
-
24
-
-
0036301851
-
Epidemiology, treatment and outcome of candidemia: A five-year review at three Canadian hospitals
-
DOI 10.1046/j.1439-0507.2002.00741.x
-
Macphail, G.L.; Taylor, G.D.; Buchanan-Chell, M.; Ross, C.; Wilson, S.; Kureishi, A. Epidemiology, treatment and outcome of candidemia: a fiveyear review at three Canadian hospitals. Mycoses, 2002, 45, 141-145. (Pubitemid 34743916)
-
(2002)
Mycoses
, vol.45
, Issue.5-6
, pp. 141-145
-
-
Macphail, G.L.P.1
Taylor, G.D.2
Buchanan-Chell, M.3
Ross, C.4
Wilson, S.5
Kureishi, A.6
-
25
-
-
0036630592
-
Candidemia in French hospitals: Incidence rates and characteristics
-
DOI 10.1046/j.1469-0691.2002.00446.x
-
Richet, H.; Roux, P.; Des Champs, C.; Esnault, Y.; Andremont, A. Candidemia in French hospitals: incidence rates and characteristics. The French Candidemia Study Group. Clin. Microbiol. Infect., 2002, 8, 405-412. (Pubitemid 34993817)
-
(2002)
Clinical Microbiology and Infection
, vol.8
, Issue.7
, pp. 405-412
-
-
Richet, H.1
Roux, P.2
Des Champs, C.3
Esnault, Y.4
Andremont, A.5
-
26
-
-
0242323689
-
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
-
DOI 10.1016/S1473-3099(03)00801-6
-
Eggimann, P.; Garbino, J.; Pittet, D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet. Infect. Dis., 2003, 3, 685-702. (Pubitemid 37345347)
-
(2003)
Lancet Infectious Diseases
, vol.3
, Issue.11
, pp. 685-702
-
-
Eggimann, P.1
Garbino, J.2
Pittet, D.3
-
27
-
-
3142726042
-
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program
-
DOI 10.1128/JCM.42.4.1519-1527.2004
-
Hajjeh, R.A.; Sofair, A.N.; Harrison, L.H.; Lyon, G.M.; Arthington-Skaggs, B.A.; Mirza, S.A.; Phelan, M.; Morgan, J.; Lee-Yang, W.; Ciblak, M.A.; Benjamin, L.E.; Sanza, L.T.; Huie, S.; Yeo, S.F.; Brandt, M.E.; Warnock, D.W. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a populationbased active surveillance program. J. Clin. Microbiol., 2004, 42, 1519-1527. (Pubitemid 38500790)
-
(2004)
Journal of Clinical Microbiology
, vol.42
, Issue.4
, pp. 1519-1527
-
-
Hajjeh, R.A.1
Sofair, A.N.2
Harrison, L.H.3
Lyon, G.M.4
Arthington-Skaggs, B.A.5
Mirza, S.A.6
Phelan, M.7
Morgan, J.8
Lee-Yang, W.9
Ciblak, M.A.10
Benjamin, L.E.11
Sanza, L.T.12
Huie, S.13
Yeo, S.F.14
Brandt, M.E.15
Warnock, D.W.16
-
28
-
-
33646150918
-
Candidaemia in Europe: Epidemiology and resistance
-
Tortorano, A.M.; Kibbler, C.; Peman, J.; Bernhardt, H.; Klingspor, L.; Grillot, R. Candidaemia in Europe: epidemiology and resistance. Int. J. Antimicrob. Agents, 2006, 27, 359-366.
-
(2006)
Int. J. Antimicrob. Agents
, vol.27
, pp. 359-366
-
-
Tortorano, A.M.1
Kibbler, C.2
Peman, J.3
Bernhardt, H.4
Klingspor, L.5
Grillot, R.6
-
29
-
-
33747165092
-
Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers
-
DOI 10.1128/JCM.00773-06
-
Colombo, A.L.; Nucci, M.; Park, B.J.; Nouér, S.A.; Arthington-Skaggs, B.; da Matta, D.A.; Warnock, D.; Morgan, J. Brazilian Network Candidemia Study Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol., 2006, 44, 2816-2823. (Pubitemid 44228575)
-
(2006)
Journal of Clinical Microbiology
, vol.44
, Issue.8
, pp. 2816-2823
-
-
Colombo, A.L.1
Nucci, M.2
Park, B.J.3
Nouer, S.A.4
Arthington-Skaggs, B.5
Da Matta, D.A.6
Warnock, D.7
Morgan, J.8
-
30
-
-
0036922412
-
Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: Increased susceptibility of Candida species to fluconazole
-
Hsueh, P.R.; Teng, L.J.; Yang, P.C.; Ho, S.W.; Luh, K.T. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb. Drug. Resist., 2002, 8, 311-319.
-
(2002)
Microb. Drug. Resist.
, vol.8
, pp. 311-319
-
-
Hsueh, P.R.1
Teng, L.J.2
Yang, P.C.3
Ho, S.W.4
Luh, K.T.5
-
32
-
-
10844242763
-
Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil
-
DOI 10.1128/JCM.42.12.5925-5927.2004
-
Portela, M.B.; Souza, I.P.; Costa, E.M.; Hagler, A.N.; Soares, R.M.A.; Santos, A.L.S. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil. J Clin. Microbiol., 2004, 42, 5925-5927. (Pubitemid 39664397)
-
(2004)
Journal of Clinical Microbiology
, vol.42
, Issue.12
, pp. 5925-5927
-
-
Portela, M.B.1
Souza, I.P.R.2
Costa, E.M.M.B.3
Hagler, A.N.4
Soares, R.M.A.5
Santos, A.L.S.6
-
33
-
-
70350328702
-
Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era
-
Pinheiro, R.S.; França, T.T.; Ribeiro, C.M.; Leão, J.C.; de Souza, I.P.; Castro, G.F. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. J. Oral. Pathol. Med., 2009, 38, 613-622.
-
(2009)
J. Oral. Pathol. Med.
, vol.38
, pp. 613-622
-
-
Pinheiro, R.S.1
França, T.T.2
Ribeiro, C.M.3
Leão, J.C.4
De Souza, I.P.5
Castro, G.F.6
-
34
-
-
77949489417
-
Oropharyngeal candidiasis in the era of antiretroviral therapy
-
Thompson, G.R.; Patel, P.K.; Kirkpatrick, W.R.; Westbrook, S.D.; Berg, D.; Erlandsen, J.; Redding, S.W.; Patterson, T.F. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodr., 2010, 109, 488-495.
-
(2010)
Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodr.
, vol.109
, pp. 488-495
-
-
Thompson, G.R.1
Patel, P.K.2
Kirkpatrick, W.R.3
Westbrook, S.D.4
Berg, D.5
Erlandsen, J.6
Redding, S.W.7
Patterson, T.F.8
-
35
-
-
0025731639
-
The prevalence of oral lesions in hiv-infected homosexual and bisexual men: Three san francisco epidemiological cohorts
-
Feigal, D.W.; Katz, M.H.; Greenspan, D.; Westenhouse, J.; Winkelstein, W. Jr.; Lang, W.; Samuel, M., Buchbinder, S.P.; Hessol, N.A.; Lifson, A.R. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS, 1991, 5, 519-525.
-
(1991)
AIDS
, vol.5
, pp. 519-525
-
-
Feigal, D.W.1
Katz, M.H.2
Greenspan, D.3
Westenhouse, J.4
Winkelstein Jr., W.5
Lang, W.6
Samuel, M.7
Buchbinder, S.P.8
Hessol, N.A.9
Lifson, A.R.10
-
36
-
-
0033112644
-
Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
-
Dios, P.D.; Ocampo, A.; Miralles, C.; Otero, I.; Iglesias, I.; Rayo, N. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 1999, 87, 437-441.
-
(1999)
Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod.
, vol.87
, pp. 437-441
-
-
Dios, P.D.1
Ocampo, A.2
Miralles, C.3
Otero, I.4
Iglesias, I.5
Rayo, N.6
-
37
-
-
0034297286
-
Changing prevalence of human immunodeficiency virus-associated oral lesions
-
Dios, P.D.; Ocampo, A.; Miralles, C.; Limeres, J.; Tomas, I. Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 2000, 90, 403-404.
-
(2000)
Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod.
, vol.90
, pp. 403-404
-
-
Dios, P.D.1
Ocampo, A.2
Miralles, C.3
Limeres, J.4
Tomas, I.5
-
38
-
-
0021279346
-
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome
-
Klein, R.S.; Harris, C.A.; Small, C.B.; Moll, B.; Lesser, M.; Friedland, G.H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 1984, 311, 354- 358. (Pubitemid 14096744)
-
(1984)
New England Journal of Medicine
, vol.311
, Issue.6
, pp. 354-358
-
-
Klein, R.S.1
Harris, C.A.2
Small, C.B.3
-
39
-
-
0025711374
-
Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease
-
World Health Organization
-
World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly. Epidemiol. Rec., 1990, 65, 221-224.
-
(1990)
Wkly. Epidemiol. Rec.
, vol.65
, pp. 221-224
-
-
-
40
-
-
0026327763
-
Oral candidiasis as a marker of acute retrovirus illness
-
Dull, J.S.; Sem, P.; Rafanti, S.; Middleton, J.R. Oral candidiasis as a marker of acute retrovirus illness. South. Med. J., 1991, 84, 733-735.
-
(1991)
South. Med. J.
, vol.84
, pp. 733-735
-
-
Dull, J.S.1
Sem, P.2
Rafanti, S.3
Middleton, J.R.4
-
41
-
-
0027122957
-
1993 revised classification system for infection and expanded surveillance case definition for AIDS among adolescent and adults
-
Centers for Disease Control
-
Centers for Disease Control.1993 revised classification system for infection and expanded surveillance case definition for AIDS among adolescent and adults. M.M.W.R., 1992, 41, 1-19.
-
(1992)
M.M.W.R.
, vol.41
, pp. 1-19
-
-
-
42
-
-
0029080559
-
The epidemiology of vulvovaginal candidiasis among university students
-
Geiger, A.M.; Foxman, B.; Gillespie, B.W. The epidemiology of vulvovaginal candidiasis among university students. Am. J. Public. Health., 1995, 85, 1146-1148.
-
(1995)
Am. J. Public. Health.
, vol.85
, pp. 1146-1148
-
-
Geiger, A.M.1
Foxman, B.2
Gillespie, B.W.3
-
43
-
-
0030041482
-
Risk factors for vulvovaginal candidiasis: A case-control study among university students
-
Geiger, A.M.; Foxman, B. Risk factors for vulvovaginal candidiasis: a casecontrol study among university students. Epidemiology, 1996, 7, 182-187. (Pubitemid 26068052)
-
(1996)
Epidemiology
, vol.7
, Issue.2
, pp. 182-187
-
-
Geiger, A.M.1
Foxman, B.2
-
44
-
-
0031454303
-
Vaginitis
-
DOI 10.1056/NEJM199712253372607
-
Sobel, J.D. Vaginitis. N. Engl. J. Med., 1997, 337, 1896-1903. (Pubitemid 28053998)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.26
, pp. 1896-1903
-
-
Sobel, J.D.1
-
45
-
-
0030019478
-
IMMUNOPATHOGENESE DE LA CANDIDOSE VULVOVAGINALE RECURRENTE (CVVR)
-
Fidel, P.L.; Sobel, J.D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Contracept. Fertil. Sex., 1996, 24, 33-40. (Pubitemid 26053613)
-
(1996)
Contraception Fertilite Sexualite
, vol.24
, Issue.1
, pp. 33-40
-
-
Fidel Jr., P.L.1
Sobel, J.D.2
-
46
-
-
0035865166
-
Chronic vulvovaginal candidiasis
-
Nyirjesy, P. Chronic vulvovaginal candidiasis. Am. Fam. Physician., 2001, 63, 697-702. (Pubitemid 32178694)
-
(2001)
American Family Physician
, vol.63
, Issue.4
, pp. 697-702
-
-
Nyirjesy, P.1
-
47
-
-
0021816099
-
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis
-
Sobel, J.D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol., 1985, 152, 924-935. (Pubitemid 15016406)
-
(1985)
American Journal of Obstetrics and Gynecology
, vol.152
, Issue.7
, pp. 924-935
-
-
Sobel, J.D.1
-
48
-
-
0031917146
-
Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
-
DOI 10.1016/S0002-9378(98)80001-X
-
Sobel, J.D.; Faro, S.; Force, R.W.; Foxman, B.; Ledger, W.J.; Nyirjesy, P.R.; Reed, B.D.; Summers, P.R. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol., 1998, 178, 203-211. (Pubitemid 28124116)
-
(1998)
American Journal of Obstetrics and Gynecology
, vol.178
, Issue.2
, pp. 203-211
-
-
Sobel, J.D.1
Faro, S.2
Force, R.W.3
Foxman, B.4
Ledger, W.J.5
Nyirjesy, P.R.6
Reed, B.D.7
Summers, P.R.8
-
49
-
-
38049075818
-
Candida glabrata fungaemia in intensive care units
-
Ruan, S.Y.; Lee, L.N.; Jerng, J.S.; Yu, C.J.; Hsueh, P.R. Candida glabrata fungaemia in intensive care units. Clin. Microbiol. Infect., 2008, 14, 136- 140.
-
(2008)
Clin. Microbiol. Infect.
, vol.14
, pp. 136-140
-
-
Ruan, S.Y.1
Lee, L.N.2
Jerng, J.S.3
Yu, C.J.4
Hsueh, P.R.5
-
50
-
-
0042331368
-
A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
-
DOI 10.1086/376906
-
Pappas, P.G.; Rex, J.H.; Lee, J.; Hamill, R.J.; Larsen, R.A.; Powderly, W.; Kauffman, C.A.; Hyslop, N.; Mangino, J.E.; Chapman, S.; Horowitz, H.W.; Edwards, J.E.; Dismukes, W.E.; NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis., 2003, 37, 634-643. (Pubitemid 37100802)
-
(2003)
Clinical Infectious Diseases
, vol.37
, Issue.5
, pp. 634-643
-
-
Pappas, P.G.1
Rex, J.H.2
Lee, J.3
Hamill, R.J.4
Larsen, R.A.5
Powderly, W.6
Kauffman, C.A.7
Hyslop, N.8
Mangino, J.E.9
Chapman, S.10
Horowitz, H.W.11
Edwards, J.E.12
Dismukes, W.E.13
-
51
-
-
0036720774
-
Secular trend of hospital-acquired candidemia among intensive care unit patients in the united states during 1989-1999
-
National Nosocomial Infections Surveillance System Hospitals
-
Trick, W.E.; Fridkin, S.K.; Edwards, J.R.; Hajjeh, R.A.; Gaynes, R.P.; National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis., 2002, 35, 627-630.
-
(2002)
Clin. Infect. Dis.
, vol.35
, pp. 627-630
-
-
Trick, W.E.1
Fridkin, S.K.2
Edwards, J.R.3
Hajjeh, R.A.4
Gaynes, R.P.5
-
52
-
-
0026316853
-
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex: Randomized, double blind, placebo-controlled study of 100-mg oral fluconazole daily
-
Stevens, D.A.; Greene, S.I.; Lang, O.S. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex: randomized, double blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch. Intern. Med., 1991, 151, 2458-2464.
-
(1991)
Arch. Intern. Med.
, vol.151
, pp. 2458-2464
-
-
Stevens, D.A.1
Greene, S.I.2
Lang, O.S.3
-
53
-
-
0027993041
-
Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
-
DOI 10.1016/0002-9343(94)90300-X
-
Sangeorzan, J.A.; Bradley, S.F.; He, X.; Zarins, L.T.; Ridenour, G.L.; Tiballi, R.N.; Kauffman, C.A. Epidemiology of oral candidiasis in HIVinfected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med., 1994, 97, 339-346. (Pubitemid 24313093)
-
(1994)
American Journal of Medicine
, vol.97
, Issue.4
, pp. 339-346
-
-
Sangeorzan, J.A.1
Bradley, S.F.2
He, X.3
Zarins, L.T.4
Ridenour, G.L.5
Tiballi, R.N.6
Kauffman, C.A.7
-
54
-
-
0028006489
-
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis
-
Redding, S.; Smith, J.; Farinacci, G.; Rinaldi, M.; Fothergill, A.; Rhine- Chalberg, J.; Pfaller, M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis., 1994, 18, 240-242. (Pubitemid 24055265)
-
(1994)
Clinical Infectious Diseases
, vol.18
, Issue.2
, pp. 240-242
-
-
Redding, S.1
Smith, J.2
Farinacci, G.3
Rinaldi, M.4
Fothergill, A.5
Rhine-Chalberg, J.6
Pfaller, M.7
-
55
-
-
76649114370
-
Antifungal drug resistance of oral fungi
-
Niimi, M.; Firth, N.A.; Cannon, R.D. Antifungal drug resistance of oral fungi. Odontology, 2010, 98, 15-25.
-
(2010)
Odontology
, vol.98
, pp. 15-25
-
-
Niimi, M.1
Firth, N.A.2
Cannon, R.D.3
-
56
-
-
0036342893
-
Resistance of human fungal pathogens to antifungal drugs
-
Sanglard, D. Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol., 2002, 5, 379-385.
-
(2002)
Curr. Opin. Microbiol.
, vol.5
, pp. 379-385
-
-
Sanglard, D.1
-
57
-
-
1542674589
-
Immunity to fungal infections
-
Romani, L. Immunity to fungal infections. Nat. Rev. Immunol., 2004, 4, 1- 23.
-
(2004)
Nat. Rev. Immunol.
, vol.4
, pp. 1-23
-
-
Romani, L.1
-
58
-
-
20444484565
-
The immune response to fungal infections
-
DOI 10.1111/j.1365-2141.2005.05397.x
-
Shoham, S.; Levitz, S.M. The immune response to fungal infections. Br. J. Haematol., 2005, 129, 569-582. (Pubitemid 40825818)
-
(2005)
British Journal of Haematology
, vol.129
, Issue.5
, pp. 569-582
-
-
Shoham, S.1
Levitz, S.M.2
-
59
-
-
77955419767
-
Interaction of pathogenic yeasts with phagocytes: Survival, persistence and escape
-
Seider, K.; Heyken, A.; Lüttich, A.; Miramón, P.; Hube, B. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr. Opin. Microbiol. 2010, 13, 392-400.
-
(2010)
Curr. Opin. Microbiol.
, vol.13
, pp. 392-400
-
-
Seider, K.1
Heyken, A.2
Lüttich, A.3
Miramón, P.4
Hube, B.5
-
60
-
-
3042521076
-
The distinct morphogenic states of Candida albicans
-
DOI 10.1016/j.tim.2004.05.008, PII S0966842X04001180
-
Sudbery, P.; Gow, N.; Berman, J. The distinct morphogenic states of Candida albicans. Trends Microbiol., 2004, 12, 317-324. (Pubitemid 38829652)
-
(2004)
Trends in Microbiology
, vol.12
, Issue.7
, pp. 317-324
-
-
Sudbery, P.1
Gow, N.2
Berman, J.3
-
61
-
-
4143081347
-
Candida morphogenesis and host-pathogen interactions
-
DOI 10.1016/j.mib.2004.06.005, PII S1369527404000712
-
Whiteway, M.; Oberholzer, U. Candida morphogenesis and host-pathogen interactions. Curr. Opin. Microbiol., 2004, 7, 350-357. (Pubitemid 39091118)
-
(2004)
Current Opinion in Microbiology
, vol.7
, Issue.4
, pp. 350-357
-
-
Whiteway, M.1
Oberholzer, U.2
-
63
-
-
0036348629
-
Fungal morphogenesis and host invasion
-
Gow, N.A.; Brown, A.J.; Odds, F.C. Fungal morphogenesis and host invasion. Curr. Opin. Microbiol., 2002, 5, 366-371.
-
(2002)
Curr. Opin. Microbiol.
, vol.5
, pp. 366-371
-
-
Gow, N.A.1
Brown, A.J.2
Odds, F.C.3
-
64
-
-
0024371026
-
Bidirectional stimulation of the white-opaque transition of Candida albicans by ultraviolet irradiation
-
Morrow, B.; Anderson, J.; Wilson, J.; Soll, D.R. Bidirectional stimulation of the white-opaque transition of Candida albicans by ultraviolet irradiation. J. Gen. Microbiol., 1989, 135, 1201-1208. (Pubitemid 19135402)
-
(1989)
Journal of General Microbiology
, vol.135
, Issue.5
, pp. 1201-1208
-
-
Morrow, B.1
Anderson, J.2
Wilson, J.3
Soll, D.R.4
-
65
-
-
24344493455
-
Interaction of pathogenic fungi with host cells: Molecular and cellular approaches
-
DOI 10.1016/j.femsim.2005.05.014, PII S0928824405001471, Advances in Molecular Mycology
-
Mendes-Giannini, M.J.; Soares, C.P.; da Silva, J.L.; Andreotti, P.F. Interaction of pathogenic fungi with host cells: Molecular and cellular approaches. FEMS Immunol. Med. Microbiol., 2005, 45, 383-394. (Pubitemid 41247775)
-
(2005)
FEMS Immunology and Medical Microbiology
, vol.45
, Issue.3
, pp. 383-394
-
-
Mendes-Giannini, M.J.S.1
Soares, C.P.2
Da Silva, J.L.M.3
Andreotti, P.F.4
-
66
-
-
0033958143
-
Potential role of phospholipases in virulence and fungal pathogenesis
-
Ghannoum, M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev., 2000, 13, 122-143. (Pubitemid 30039346)
-
(2000)
Clinical Microbiology Reviews
, vol.13
, Issue.1
, pp. 122-143
-
-
Ghannoum, M.A.1
-
67
-
-
0141789642
-
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis
-
DOI 10.1128/MMBR.67.3.400-428.2003
-
Naglik, J.R.; Challacombe, S.J.; Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev., 2003, 67, 400-428. (Pubitemid 37122527)
-
(2003)
Microbiology and Molecular Biology Reviews
, vol.67
, Issue.3
, pp. 400-428
-
-
Naglik, J.R.1
Challacombe, S.J.2
Hube, B.3
-
68
-
-
33644683261
-
Hydrolytic enzymes as virulence factors of Candida albicans
-
DOI 10.1111/j.1439-0507.2005.01165.x
-
Schaller, M.; Borelli, C.; Korting, H.C.; Hube, B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses, 2005, 48, 365-377. (Pubitemid 43942679)
-
(2005)
Mycoses
, vol.48
, Issue.6
, pp. 365-377
-
-
Schaller, M.1
Borelli, C.2
Korting, H.C.3
Hube, B.4
-
69
-
-
0030310227
-
Candida albicans secreted aspartyl proteinases
-
Hube, B. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol., 1996, 7, 55-69.
-
(1996)
Curr. Top. Med. Mycol.
, vol.7
, pp. 55-69
-
-
Hube, B.1
-
70
-
-
0034872193
-
Aspartyl proteinases of Candida albicans and their role in pathogenicity
-
De Bernardis, F.; Sullivan, P.A.; Cassone, A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol., 2001, 39, 303-313.
-
(2001)
Med. Mycol.
, vol.39
, pp. 303-313
-
-
De Bernardis, F.1
Sullivan, P.A.2
Cassone, A.3
-
71
-
-
0034865464
-
Candida albicans proteinases: Resolving the mystery of a gene family
-
Hube, B.; Naglik, J. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology, 2001, 147, 1997-2005 (Pubitemid 32785481)
-
(2001)
Microbiology
, vol.147
, Issue.8
, pp. 1997-2005
-
-
Hube, B.1
Naglik, J.2
-
72
-
-
4544365934
-
Candida albicans proteinases and host/pathogen interactions
-
DOI 10.1111/j.1462-5822.2004.00439.x
-
Naglik, J.; Albrecht, A.; Bader, O.; Hube, B. Candida albicans proteinases and host/pathogen interactions. Cell. Microbiol., 2004, 6, 915-926. (Pubitemid 39255605)
-
(2004)
Cellular Microbiology
, vol.6
, Issue.10
, pp. 915-926
-
-
Naglik, J.1
Albrecht, A.2
Bader, O.3
Hube, B.4
-
73
-
-
0029128928
-
Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determined by cell type, and levels are determined by environmental factors
-
White, T.C.; Agabian, N. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J. Bacteriol., 1995, 177, 5215-5221.
-
(1995)
J. Bacteriol.
, vol.177
, pp. 5215-5221
-
-
White, T.C.1
Agabian, N.2
-
74
-
-
0027940569
-
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans
-
DOI 10.1111/j.1365-2958.1994.tb01269.x
-
Hube, B.; Monod, M.; Schofield, D.A.; Brown, A.J.; Gow, N.A. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol., 1994, 14, 87-99. (Pubitemid 24312822)
-
(1994)
Molecular Microbiology
, vol.14
, Issue.1
, pp. 87-99
-
-
Hube, B.1
Monod, M.2
Schofield, D.A.3
Brown, A.J.P.4
Gow, N.A.R.5
-
75
-
-
67649509614
-
Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species
-
Parra-Ortega, B.; Cruz-Torres, H.; Villa-Tanaca, L.; Hernández- Rodríguez, C. Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species. Mem. Inst. Oswaldo Cruz, 2009, 104, 505-512.
-
(2009)
Mem. Inst. Oswaldo Cruz
, vol.104
, pp. 505-512
-
-
Parra-Ortega, B.1
Cruz-Torres, H.2
Villa-Tanaca, L.3
Hernández- Rodríguez, C.4
-
76
-
-
0029920879
-
Acid proteinase secreted by Candida tropicalis functional analysis of preproregion cleavages in C. tropicalis and Saccharomyces cerevisiae
-
Togni, G.; Sanglard, D.; Quadroni, M.; Foundling, S.I.; Monod, M. Acid proteinase secreted by Candida tropicalis functional analysis of preproregion cleavages in C. tropicalis and Saccharomyces cerevisiae. Microbiology, 1996, 142, 493-503.
-
(1996)
Microbiology
, vol.142
, pp. 493-503
-
-
Togni, G.1
Sanglard, D.2
Quadroni, M.3
Foundling, S.I.4
Monod, M.5
-
77
-
-
0030710147
-
KEX2 influences Candida albicans proteinase secretion and hyphal formation
-
DOI 10.1074/jbc.272.46.28954
-
Newport, G.; Agabian, N. KEX2 influences Candida albicans proteinase secretion and hyphal formation. J. Biol. Chem., 1997, 272, 28954-28961. (Pubitemid 27498180)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.46
, pp. 28954-28961
-
-
Newport, G.1
Agabian, N.2
-
78
-
-
43649103148
-
-
Calderone, R.A.; Ronald, L.C., Eds.; Marcel Dekker, New York
-
Calderone, R.A.; Ronald, L.C. In: Fungal pathogenesis: principles and clinical applications; Calderone, R.A.; Ronald, L.C., Eds.; Marcel Dekker, New York, 2002; pp. 1-24.
-
(2002)
Fungal Pathogenesis: Principles and Clinical Applications
, pp. 1-24
-
-
Calderone, R.A.1
Ronald, L.C.2
-
79
-
-
0036854439
-
Differential secretion of Sap4-6 proteins Candida albicans during hyphae formation
-
Chen, Y.C.; Wu, C.C.; Chung, W.L.; Lee, F.J. Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiology, 2002, 148, 3743-3754.
-
(2002)
Microbiology
, vol.148
, pp. 3743-3754
-
-
Chen, Y.C.1
Wu, C.C.2
Chung, W.L.3
Lee, F.J.4
-
80
-
-
77950812074
-
Real-time PCR expression profiling of genes encoding potential virulence factors Candida albicans biofilms: Identification of model-dependent and -independent gene expression
-
Nailis, H.; Kucharíková, S.; Ricicová, M.; Van Dijck, P.; Deforce, D.; Nelis, H.; Coenye, T. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol., 2010, 10, 114.
-
(2010)
BMC Microbiol.
, vol.10
, pp. 114
-
-
Nailis, H.1
Kucharíková, S.2
Ricicová, M.3
Van Dijck, P.4
Deforce, D.5
Nelis, H.6
Coenye, T.7
-
81
-
-
25444454561
-
Induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice
-
DOI 10.1128/IAI.73.10.7061-7063.2005
-
Taylor, B.N.; Hannemann, H.; Sehnal, M.; Biesemeier, A.; Schweizer, A.; Röllinghoff, M.; Schröppel, K. Induction of sap7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice. Infect. Immun., 2005, 73, 7061-7063. (Pubitemid 41368882)
-
(2005)
Infection and Immunity
, vol.73
, Issue.10
, pp. 7061-7063
-
-
Taylor, B.N.1
Hannemann, H.2
Sehnal, M.3
Biesemeier, A.4
Schweizer, A.5
Rollinghoff, M.6
Schroppel, K.7
-
82
-
-
0031765521
-
Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans
-
Monod, M.; Hube, B.; Hess, D.; Sanglard, D. Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology, 1998, 144, 2731-2737. (Pubitemid 28486422)
-
(1998)
Microbiology
, vol.144
, Issue.10
, pp. 2731-2737
-
-
Monod, M.1
Hube, B.2
Hess, D.3
Sanglard, D.4
-
83
-
-
33644861572
-
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host pathogen interactions
-
Albrecht, A.; Felk, A.; Pichova, I.; Naglik, J.R.; Schaller, M.; de Groot, P.; Maccallum, D.; Odds, F.C.; Schafer, W.; Klis, F.; Monod, M.; Hube, B. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host pathogen interactions. J. Biol. Chem., 2006, 281, 688-694.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 688-694
-
-
Albrecht, A.1
Felk, A.2
Pichova, I.3
Naglik, J.R.4
Schaller, M.5
De Groot, P.6
MacCallum, D.7
Odds, F.C.8
Schafer, W.9
Klis, F.10
Monod, M.11
Hube, B.12
-
84
-
-
78651507997
-
Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10
-
Schild, L.; Heyken, A.; de Groot, P.W.; Hiller, E.; Mock, M.; de Koster, C.; Horn, U.; Rupp, S.; Hube, B. Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10. Eukaryot. Cell, 2011, 10, 98-109.
-
(2011)
Eukaryot. Cell
, vol.10
, pp. 98-109
-
-
Schild, L.1
Heyken, A.2
De Groot, P.W.3
Hiller, E.4
Mock, M.5
De Koster, C.6
Horn, U.7
Rupp, S.8
Hube, B.9
-
85
-
-
4143131048
-
Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns
-
DOI 10.1128/EC.3.2.536-545.2004
-
García-Sánchez, S.; Aubert, S.; Iraqui, I.; Janbon, G.; Ghigo, J.M.; d'Enfert, C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell, 2004, 3, 536-545. (Pubitemid 38497991)
-
(2004)
Eukaryotic Cell
, vol.3
, Issue.2
, pp. 536-545
-
-
Garcia-Sanchez, S.1
Aubert, S.2
Iraqui, I.3
Janbon, G.4
Ghigo, J.-M.5
D'Enfert, C.6
-
86
-
-
18844462400
-
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes
-
DOI 10.1093/jac/dki088
-
Copping, V.M.; Barelle, C.J.; Hube, B.; Gow, N.A.; Brown, A.J.; Odds. F.C. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J. Antimicrob. Chemother., 2005, 55, 645-654. (Pubitemid 40691842)
-
(2005)
Journal of Antimicrobial Chemotherapy
, vol.55
, Issue.5
, pp. 645-654
-
-
Copping, V.M.S.1
Barelle, C.J.2
Hube, B.3
Gow, N.A.R.4
Brown, A.J.P.5
Odds, F.C.6
-
87
-
-
0021071625
-
On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro
-
Rüchel, R. On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro. Zentralbl. Bakteriol. Mikrobiol. Hyg. A, 1983, 255, 368-379. (Pubitemid 14238057)
-
(1983)
Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene - Abt. 1 Orig. A
, vol.255
, Issue.2-3
, pp. 368-379
-
-
Ruchel, R.1
-
88
-
-
0020558198
-
Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin
-
DOI 10.1016/0022-1759(83)90014-5
-
Rüchel, R.; Böning, B. Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin. J. Immunol. Methods, 1983, 61, 107-116. (Pubitemid 13106595)
-
(1983)
Journal of Immunological Methods
, vol.61
, Issue.1
, pp. 107-116
-
-
Ruchel, R.1
Boning, B.2
-
89
-
-
0025354608
-
Activation of the plasma kallikrein-kinin system by Candida albicans proteinase
-
Kaminishi, H.; Tanaka, M.; Cho, T.; Maeda, H.; Hagihara, Y. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect. Immun., 1990, 58, 2139-2143. (Pubitemid 20212287)
-
(1990)
Infection and Immunity
, vol.58
, Issue.7
, pp. 2139-2143
-
-
Kaminishi, H.1
Tanaka, M.2
Cho, T.3
Maeda, H.4
Hagihara, Y.5
-
90
-
-
0028968826
-
Degradation of humoral host defense by Candida albicans proteinase
-
Kaminishi, H.; Miyaguchi, H.; Tamaki, T.; Suenaga, N.; Hisamatsu, M.; Mihashi, I.; Matsumoto, H.; Maeda, H.; Hagihara, Y. Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun., 1995, 63, 984-988.
-
(1995)
Infect. Immun.
, vol.63
, pp. 984-988
-
-
Kaminishi, H.1
Miyaguchi, H.2
Tamaki, T.3
Suenaga, N.4
Hisamatsu, M.5
Mihashi, I.6
Matsumoto, H.7
Maeda, H.8
Hagihara, Y.9
-
91
-
-
0028082364
-
Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
-
Tsushima, H.; Mine, H.; Kawakami, Y.; Hyodoh, F.; Ueki, A. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology, 1994, 140, 167-171. (Pubitemid 24067323)
-
(1994)
Microbiology
, vol.140
, Issue.1
, pp. 167-171
-
-
Tsushima, H.1
Mine, H.2
Kawakami, Y.3
Hyodoh, F.4
Ueki, A.5
-
92
-
-
0029961316
-
Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase
-
Colina, A.R.; Aumont, F.; Deslauriers, N.; Belhumeur, P.; de Repentigny, L. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun., 1996, 64, 4514-4519. (Pubitemid 26357052)
-
(1996)
Infection and Immunity
, vol.64
, Issue.11
, pp. 4514-4519
-
-
Colina, A.-R.1
Aumont, F.2
Deslauriers, N.3
Belhumeur, P.4
De Repentigny, L.5
-
93
-
-
2642709181
-
Proteolytic activation of the interleukin-1beta precursor by
-
Beauséjour, A.; Grenier, D.; Goulet, J.P.; Deslauriers, N. Proteolytic activation of the interleukin-1beta precursor by Candida albicans. Infect. Immun., 1998, 66, 676-581.
-
(1998)
Candida Albicans. Infect. Immun.
, vol.66
, pp. 676-581
-
-
Beauséjour, A.1
Grenier, D.2
Goulet, J.P.3
Deslauriers, N.4
-
94
-
-
0032859994
-
The expression of secreted aspartyl proteinases of Candida species in human whole saliva
-
Wu, T.; Samaranayake, L.P. The expression of secreted aspartyl proteinases of Candida species in human whole saliva. J. Med. Microbiol., 1999, 48, 711-720. (Pubitemid 29478891)
-
(1999)
Journal of Medical Microbiology
, vol.48
, Issue.8
, pp. 711-720
-
-
Wu, T.1
Samaranayake, L.P.2
-
95
-
-
0037224565
-
Internalisation and degradation of histatin 5 by
-
Ruissen, A.L.; Groenink, J.; Krijtenberg, P.; Walgreen-Weterings, E.; van 't Hof, W.; Veerman, E.C.; Nieuw Amerongen, A.V. Internalisation and degradation of histatin 5 by Candida albicans. Biol. Chem., 2003, 384, 183- 190.
-
(2003)
Candida Albicans. Biol. Chem.
, vol.384
, pp. 183-190
-
-
Ruissen, A.L.1
Groenink, J.2
Krijtenberg, P.3
Walgreen-Weterings, E.4
Van 'T Hof, W.5
Veerman, E.C.6
Nieuw Amerongen, A.V.7
-
96
-
-
70450225229
-
The yeast Candida albicans evades human complement attack by secretion of aspartic proteases
-
Gropp, K.; Schild, L.; Schindler, S.; Hube, B.; Zipfel, P.F.; Skerka, C. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol. Immunol., 2009, 47, 465-475.
-
(2009)
Mol. Immunol.
, vol.47
, pp. 465-475
-
-
Gropp, K.1
Schild, L.2
Schindler, S.3
Hube, B.4
Zipfel, P.F.5
Skerka, C.6
-
97
-
-
52049086866
-
Secreted proteins of Candida albicans
-
Hruskova-Heidingsfeldova, O. Secreted proteins of Candida albicans. Front. Biosci., 2008, 13, 7227-7242.
-
(2008)
Front. Biosci.
, vol.13
, pp. 7227-7242
-
-
Hruskova-Heidingsfeldova, O.1
-
98
-
-
0028040508
-
Activation of blood clotting factors by microbial proteinases
-
DOI 10.1016/0378-1097(94)90312-3
-
Kaminishi, H.; Hamatake, H.; Cho, T.; Tamaki, T.; Suenaga, N.; Fujii, T.; Hagihara, Y.; Maeda, H. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol. Lett., 1994,121, 327-332. (Pubitemid 24264804)
-
(1994)
FEMS Microbiology Letters
, vol.121
, Issue.3
, pp. 327-332
-
-
Kaminishi, H.1
Hamatake, H.2
Cho, T.3
Tamaki, T.4
Suenaga, N.5
Fujii, T.6
Hagihara, Y.7
Maeda, H.8
-
99
-
-
0028986896
-
Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase
-
Tsushima, H.; Mine, H. Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase. FEMS Immunol. Med. Microbiol., 1995,11, 69- 72.
-
(1995)
FEMS Immunol. Med. Microbiol.
, vol.11
, pp. 69-72
-
-
Tsushima, H.1
Mine, H.2
-
100
-
-
57349131646
-
Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by
-
Lermann, U.; Morschhäuser, J. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology, 2008, 154, 3281-3295.
-
(2008)
Candida Albicans. Microbiology
, vol.154
, pp. 3281-3295
-
-
Lermann, U.1
Morschhäuser, J.2
-
101
-
-
0030884478
-
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence
-
Hube, B.; Sanglard, D.; Odds, F.C.; Hess, D.; Monod, M.; Schafer, W.; Brown, A.J.; Gow, N.A. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun., 1997, 65, 3529-3538. (Pubitemid 27398104)
-
(1997)
Infection and Immunity
, vol.65
, Issue.9
, pp. 3529-3538
-
-
Hube, B.1
Sanglard, D.2
Odds, F.C.3
Hess, D.4
Monod, M.5
Schafer, W.6
Brown, A.J.P.7
Gow, N.A.R.8
-
102
-
-
0030884697
-
A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence
-
Sanglard, D.; Hube, B.; Monod, M.; Odds, F.C.; Gow, N.A. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun., 1997, 65, 3539-3546. (Pubitemid 27398105)
-
(1997)
Infection and Immunity
, vol.65
, Issue.9
, pp. 3539-3546
-
-
Sanglard, D.1
Hube, B.2
Monod, M.3
Odds, F.C.4
Gow, N.A.R.5
-
103
-
-
0032728551
-
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis
-
Kretschmar, M.; Hube, B.; Bertsch, T.; Sanglard, D.; Merker, R.; Schroder, M.; Hof, H.; Nichterlein, T. Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect. Immun., 1999, 67, 6637-6642.
-
(1999)
Infect. Immun.
, vol.67
, pp. 6637-6642
-
-
Kretschmar, M.1
Hube, B.2
Bertsch, T.3
Sanglard, D.4
Merker, R.5
Schroder, M.6
Hof, H.7
Nichterlein, T.8
-
104
-
-
0004790502
-
Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis
-
DOI 10.1086/314546
-
De Bernardis, F.; Arancia, S.; Morelli, L.; Hube, B.; Sanglard, D.; Schafer, W.; Cassone, A. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis., 1999, 179, 201-208. (Pubitemid 29028356)
-
(1999)
Journal of Infectious Diseases
, vol.179
, Issue.1
, pp. 201-208
-
-
De Bernardis, F.1
Arancia, S.2
Morelli, L.3
Hube, B.4
Sanglard, D.5
Schafer, W.6
Cassone, A.7
-
105
-
-
0001421998
-
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis
-
DOI 10.1046/j.1365-2958.1999.01590.x
-
Schaller, M.; Korting, H.C.; Schafer, W.; Bastert, J.; Chen, W.; Hube, B. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol., 1999, 34, 169-180. (Pubitemid 29460495)
-
(1999)
Molecular Microbiology
, vol.34
, Issue.1
, pp. 169-180
-
-
Schaller, M.1
Korting, H.C.2
Schafer, W.3
Bastert, J.4
Chen, W.5
Hube, B.6
-
106
-
-
0037767275
-
The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
-
DOI 10.1128/IAI.71.6.3227-3234.2003
-
Schaller, M.; Bein, M.; Korting, H.C.; Baur, S.; Hamm, G.; Monod, M.; Beinhauer, S.; Hube, B. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect. Immun., 2003, 71, 3227- 3234. (Pubitemid 36637547)
-
(2003)
Infection and Immunity
, vol.71
, Issue.6
, pp. 3227-3234
-
-
Schaller, M.1
Bein, M.2
Korting, H.C.3
Baur, S.4
Hamm, G.5
Monod, M.6
Beinhauer, S.7
Hube, B.8
-
107
-
-
57349145280
-
Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
-
Naglik, J.R.; Moyes, D.; Makwana, J.; Kanzaria, P.; Tsichlaki, E.; Weindl, G.; Tappuni, A.R.; Rodgers, C.A.; Woodman, A.J.; Challacombe, S.J.; Schaller, M.; Hube, B. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology, 2008, 154, 3266-3280.
-
(2008)
Microbiology
, vol.154
, pp. 3266-3280
-
-
Naglik, J.R.1
Moyes, D.2
Makwana, J.3
Kanzaria, P.4
Tsichlaki, E.5
Weindl, G.6
Tappuni, A.R.7
Rodgers, C.A.8
Woodman, A.J.9
Challacombe, S.J.10
Schaller, M.11
Hube, B.12
-
108
-
-
34648843431
-
The role of secreted aspartyl proteinases in Candida albicans keratitis
-
DOI 10.1167/iovs.07-0114
-
Jackson, B.E.; Wilhelmus, K.R.; Hube, B. The role of secreted aspartyl proteinases in Candida albicans keratitis. Invest. Ophthalmol. Vis. Sci., 2007, 48, 3559-3565. (Pubitemid 351261090)
-
(2007)
Investigative Ophthalmology and Visual Science
, vol.48
, Issue.8
, pp. 3559-3565
-
-
Jackson, B.E.1
Wilhelmus, K.R.2
Hube, B.3
-
109
-
-
0036081594
-
Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs
-
DOI 10.1128/IAI.70.7.3689-3700.2002
-
Felk, A.; Kretschmar, M.; Albrecht, A.; Schaller, M.; Beinhauer, S.; Nichterlein, T.; Sanglard, D.; Korting, H.C.; Schäfer, W.; Hube, B. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect. Immun., 2002, 70, 3689-3700. (Pubitemid 34666008)
-
(2002)
Infection and Immunity
, vol.70
, Issue.7
, pp. 3689-3700
-
-
Felk, A.1
Kretschmar, M.2
Albrecht, A.3
Schaller, M.4
Beinhauer, S.5
Nichterlein, T.6
Sanglard, D.7
Korting, H.C.8
Schafer, W.9
Hube, B.10
-
110
-
-
72449188627
-
The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils
-
Hornbach, A.; Heyken, A.; Schild, L.; Hube, B.; Löffler, J.; Kurzai, O. The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils. Infect. Immun., 2009, 77, 5216-5224.
-
(2009)
Infect. Immun.
, vol.77
, pp. 5216-5224
-
-
Hornbach, A.1
Heyken, A.2
Schild, L.3
Hube, B.4
Löffler, J.5
Kurzai, O.6
-
111
-
-
0043159196
-
Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections
-
DOI 10.1086/376536
-
Naglik, J.R.; Rodgers, C.A.; Shirlaw, P.J.; Dobbie, J.L.; Fernandes-Naglik, L.L.; Greenspan, D.; Agabian, N.; Challacombe, S.J. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis., 2003, 188, 469-479. (Pubitemid 36960660)
-
(2003)
Journal of Infectious Diseases
, vol.188
, Issue.3
, pp. 469-479
-
-
Naglik, J.R.1
Rodgers, C.A.2
Shirlaw, P.J.3
Dobbie, J.L.4
Fernandes-Naglik, L.L.5
Greenspan, D.6
Agabian, N.7
Challacombe, S.J.8
-
112
-
-
0032900510
-
In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis
-
Naglik, J.R.; Newport, G.; White, T.C.; Fernandes-Naglik, L.L.; Greenspan, J.S.; Greenspan, D.; Sweet, S.P.; Challacombe, S.J.; Agabian, N. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun., 1999, 67, 2482-2490. (Pubitemid 29200509)
-
(1999)
Infection and Immunity
, vol.67
, Issue.5
, pp. 2482-2490
-
-
Naglik, J.R.1
Newport, G.2
White, T.C.3
Fernandes-Naglik, L.L.4
Greenspan, J.S.5
Greenspan, D.6
Sweet, S.P.7
Challacombe, S.J.8
Agabian, N.9
-
113
-
-
34248370072
-
Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p
-
DOI 10.1128/IAI.00054-07
-
Villar, C.C.; Kashleva, H.; Nobile, C.J.; Mitchell, A.P.; Dongari-Bagtzoglou, A. Mucosal tissue invasion by Candida albicans is associated with Ecadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun., 2007, 75, 2126-2135. (Pubitemid 46744298)
-
(2007)
Infection and Immunity
, vol.75
, Issue.5
, pp. 2126-2135
-
-
Villar, C.C.1
Kashleva, H.2
Nobile, C.J.3
Mitchell, A.P.4
Dongari-Bagtzoglou, A.5
-
114
-
-
0034705055
-
Differential activation of a Candida albicans virulence gene family during infection
-
DOI 10.1073/pnas.110031497
-
Staib, P.; Kretschmar, M.; Nichterlein, T.; Hof, H.; Morschhäuser, J. Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 6102-6107. (Pubitemid 30367530)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.11
, pp. 6102-6107
-
-
Staib, P.1
Kretschmar, M.2
Nichterlein, T.3
Hof, H.4
Morschhauser, J.5
-
115
-
-
15544379826
-
Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection
-
DOI 10.1128/IAI.73.3.1828-1835.2005
-
Taylor, B.N.; Staib, P.; Binder, A.; Biesemeier, A.; Sehnal, M.; Rollinghoff, M.; Morschhauser, J.; Schroppel, K. Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infect. Immun., 2005, 73, 1828-1835. (Pubitemid 40470772)
-
(2005)
Infection and Immunity
, vol.73
, Issue.3
, pp. 1828-1835
-
-
Taylor, B.N.1
Staib, P.2
Binder, A.3
Biesemeier, A.4
Sehnal, M.5
Rollinghoff, M.6
Morschhauser, J.7
Schroppel, K.8
-
116
-
-
0036354556
-
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice
-
DOI 10.1006/mpat.2001.0478
-
Kretschmar, M.; Felk, A.; Staib, P.; Schaller, M.; Hess, D.; Callapina, M.; Morschhäuser, J.; Schäfer, W.; Korting, H.C.; Hof, H.; Hube, B.; Nichterlein, T. Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans arenot essential for invasion and colonization of the gastrointestinal tract in mice. Microb. Pathog., 2002, 32, 61-70. (Pubitemid 34969207)
-
(2002)
Microbial Pathogenesis
, vol.32
, Issue.2
, pp. 61-70
-
-
Kretschmar, M.1
Felk, A.2
Staib, P.3
Schaller, M.4
Hess, D.5
Callapina, M.6
Morschhauser, J.7
Schafer, W.8
Korting, H.C.9
Hof, H.10
Hube, B.11
Nichterlein, T.12
-
117
-
-
2642709181
-
Proteolytic activation of the interleukin-1β precursor by Candida albicans
-
Beausejour, A.; Grenier, D.; Goulet, J.P.; Deslauriers, N. Proteolytic activation of the interleukin-1beta precursor by Candida albicans. Infect. Immun., 1998, 66, 676-681. (Pubitemid 28074212)
-
(1998)
Infection and Immunity
, vol.66
, Issue.2
, pp. 676-681
-
-
Beausejour, A.1
Grenier, D.2
Goulet, J.-P.3
Deslauriers, N.4
-
118
-
-
17644403191
-
Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis
-
DOI 10.1128/IAI.73.5.2758-2765.2005
-
Schaller, M.; Korting, H.C.; Borelli, C.; Hamm, G.; Hube, B. Candida albicans secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect. Immun., 2005, 73, 2758- 2765. (Pubitemid 40570342)
-
(2005)
Infection and Immunity
, vol.73
, Issue.5
, pp. 2758-2765
-
-
Schaller, M.1
Korting, H.C.2
Borelli, C.3
Hamm, G.4
Hube, B.5
-
119
-
-
78049441695
-
The inflammatory response induced by aspartic proteases of candida albicans is independent of proteolytic activity
-
Pietrella, D.; Rachini, A.; Pandey, N.; Schild, L.; Netea, M..; Bistoni, F.; Hube, B.; Vecchiarelli, A. The Inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity. Infect. Immun., 2010, 78, 4754-4762.
-
(2010)
Infect. Immun.
, vol.78
, pp. 4754-4762
-
-
Pietrella, D.1
Rachini, A.2
Pandey, N.3
Schild, L.4
Netea, M.5
Bistoni, F.6
Hube, B.7
Vecchiarelli, A.8
-
120
-
-
0023874209
-
Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa
-
Borg, M.; Rüchel, R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun., 1988, 56, 626-631. (Pubitemid 18058793)
-
(1988)
Infection and Immunity
, vol.56
, Issue.3
, pp. 626-631
-
-
Borg, M.1
Ruchel, R.2
-
121
-
-
0025994337
-
Candidiasis visualised by proteinase-directed immunofluorescence
-
Rüchel, R.; Zimmermann, F.; Boning-Stutzer, B.; Helmchen, U. Candidiasis visualised by proteinase-directed immunofluorescence. Virchows Arch. A. Pathol. Anat. Histopathol., 1991, 419, 199-202.
-
(1991)
Virchows Arch. A. Pathol. Anat. Histopathol.
, vol.419
, pp. 199-202
-
-
Rüchel, R.1
Zimmermann, F.2
Boning-Stutzer, B.3
Helmchen, U.4
-
122
-
-
0025108055
-
Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis
-
Borg, M.; Rüchel, R. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J. Med. Veter. Mycol., 1990, 28, 3-14. (Pubitemid 20308812)
-
(1990)
Journal of Medical and Veterinary Mycology
, vol.28
, Issue.1
, pp. 3-14
-
-
Borg, M.1
Ruchel, R.2
-
123
-
-
0023937005
-
A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data
-
Rüchel, R.; Böning, B.; Mari, A. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses, 1988, 31, 87-106.
-
(1988)
Mycoses
, vol.31
, pp. 87-106
-
-
Rüchel, R.1
Böning, B.2
Mari, A.3
-
124
-
-
0141675198
-
Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis
-
DOI 10.1128/CDLI.10.5.835-848.2003
-
Morrison, C.J.; Hurst, S.F.; Reiss, E. Competitive binding inhibition enzymelinked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin. Diagn. Lab. Immunol., 2003, 10, 835-848. (Pubitemid 37129497)
-
(2003)
Clinical and Diagnostic Laboratory Immunology
, vol.10
, Issue.5
, pp. 835-848
-
-
Morrison, C.J.1
Hurst, S.F.2
Reiss, E.3
-
125
-
-
0021019334
-
Secretion of acid proteinases by different species of the genus Candida
-
Rüchel, R.; Uhlemann, K.; Böning, B. Secretion of acid proteinases by different species of the genus Candida. Zbl. Bakt. Hyg. I. Abt. Orig. A, 1983, 255, 537-548. (Pubitemid 14195791)
-
(1983)
Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene - Abt. 1 Orig. A
, vol.255
, Issue.4
, pp. 537-548
-
-
Ruchel, R.1
Uhlemann, K.2
Boning, B.3
-
126
-
-
84907135425
-
Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans
-
Ghannoum, M.; Abu Elteen, K. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol., 1986, 24, 407-413.
-
(1986)
J. Med. Vet. Mycol.
, vol.24
, pp. 407-413
-
-
Ghannoum, M.1
Abu Elteen, K.2
-
127
-
-
0023205221
-
Evidence for a correlation between proteinase secretion and vulvovaginal candidosis
-
Cassone, A.; De Bernardis, F.; Mondello, F.; Ceddia, T.; Agatensi, L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis., 1987, 156, 777-783. (Pubitemid 17157428)
-
(1987)
Journal of Infectious Diseases
, vol.156
, Issue.5
, pp. 777-783
-
-
Cassone, A.1
De Bernardis, F.2
Mondello, F.3
Ceddia, T.4
Agatensi, L.5
-
128
-
-
0029122456
-
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients
-
Ollert, M.W.; Wende, C.; Görlich, M.; McMullan-Vogel, C.G.; Borg-von Zepelin, M.; Vogel, C.W.; Korting, H.C. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol., 1995, 33, 2543-2549.
-
(1995)
J. Clin. Microbiol.
, vol.33
, pp. 2543-2549
-
-
Ollert, M.W.1
Wende, C.2
Görlich, M.3
McMullan-Vogel, C.G.4
Borg-Von Zepelin, M.5
Vogel, C.W.6
Korting, H.C.7
-
129
-
-
0030031314
-
Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus
-
De Bernardis, F.; Chiani, P.; Ciccozzi, M.; Pellegrini, G.; Ceddia, T.; D'Offizzi, G.; Quinti, I.; Sullivan, P.A.; Cassone, A. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun., 1996, 64, 466-471. (Pubitemid 26032815)
-
(1996)
Infection and Immunity
, vol.64
, Issue.2
, pp. 466-471
-
-
De Bernardis, F.1
Chiani, P.2
Ciccozzi, M.3
Pellegrini, G.4
Ceddia, T.5
D'Offizzi, G.6
Quinti, I.7
Sullivan, P.A.8
Cassone, A.9
-
130
-
-
0020663680
-
Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant
-
MacDonald, F.; Odds, F.C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol., 1983,129, 431-438. (Pubitemid 13186931)
-
(1983)
Journal of General Microbiology
, vol.129
, Issue.2
, pp. 431-438
-
-
MacDonald, F.1
Odds, F.C.2
-
131
-
-
0025240749
-
The secreted aspartate proteinase of Candida albicans: Physiology of secretion and virulence of a proteinase-deficient mutant
-
Ross, I.K.; De Bernardis, F.; Emerson, G.W.; Cassone, A.; Sullivan, P.A. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J. Gen. Microbiol., 1990,136, 687-694. (Pubitemid 20136542)
-
(1990)
Journal of General Microbiology
, vol.136
, Issue.4
, pp. 687-694
-
-
Ross, I.K.1
De Bernardis, F.2
Emerson, G.W.3
Cassone, A.4
Sullivan, P.A.5
-
132
-
-
27844483770
-
The determination of some virulence factors (phospholipase, protease, germ tube formation and adherence) of C. albicans and the correlative relationship of these factors
-
Yücel, A.; Kantarcioglu, A.S. The determination of some virulence factors (phospholipase, protease, germ tube formation and adherence) of C. albicans and the correlative relationship of these factors. Turk. J. Infect., 2001, 15, 517-525.
-
(2001)
Turk. J. Infect.
, vol.15
, pp. 517-525
-
-
Yücel, A.1
Kantarcioglu, A.S.2
-
133
-
-
0031958486
-
Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro
-
Gruber, A.; Lukasser-Vogl, E.; Borg-von Zepelin, M.; Dierich, M.P.; Würzner, R. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Dis., 1998, 177, 1057-1063. (Pubitemid 28155162)
-
(1998)
Journal of Infectious Diseases
, vol.177
, Issue.4
, pp. 1057-1063
-
-
Gruber, A.1
Lukasser-Vogl, E.2
Borg-Von Zepelin, M.3
Dierich, M.P.4
Wurzner, R.5
-
134
-
-
0037722830
-
HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion
-
DOI 10.1016/S0928-8244(03)00110-X
-
Gruber, A.; Lell, C.P.; Spruth, M.; Lass-Flörl, C.; Speth, C.; Stoiber, H.; Hube, B.; Coleman, D.; Polonelli, L.; Dierich, M.P.; Würzner, R. HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion. FEMS Immunol. Med. Microbiol., 2003, 37, 77-83. (Pubitemid 36588930)
-
(2003)
FEMS Immunology and Medical Microbiology
, vol.37
, Issue.1
, pp. 77-83
-
-
Gruber, A.1
Lell, C.P.2
Spruth, M.3
Lass-Florl, C.4
Speth, C.5
Stoiber, H.6
Hube, B.7
Coleman, D.8
Polonelli, L.9
Dierich, M.P.10
Wurzner, R.11
-
135
-
-
0014784381
-
Pepstatin, a new peptide inhibitor produced by actinomycetes
-
Umezawa, H.; Aoyagi, T.; Morishima, H.; Matsuzaki, M.; Hamada, M; Takeuchi, T. Pepstatin, a new peptide inhibitor produced by actinomycetes. J. Antibiotics, 1970, 23, 259-262.
-
(1970)
J. Antibiotics
, vol.23
, pp. 259-262
-
-
Umezawa, H.1
Aoyagi, T.2
Morishima, H.3
Matsuzaki, M.4
Hamada, M.5
Takeuchi, T.6
-
136
-
-
0032007999
-
Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes
-
DOI 10.1016/S0378-1097(97)00559-4, PII S0378109797005594
-
Watts, H.J.; Cheah, F.S.; Hube, B.; Sanglard, D.; Gow, N.A. Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol. Lett., 1998, 159, 129- 135. (Pubitemid 28051355)
-
(1998)
FEMS Microbiology Letters
, vol.159
, Issue.1
, pp. 129-135
-
-
Watts, H.J.1
Cheah, F.S.H.2
Hube, B.3
Sanglard, D.4
Gow, N.A.R.5
-
137
-
-
77649229368
-
Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes
-
Dalle, F.; Wächtler, B.; L'Ollivier, C.; Holland, G.; Bannert, N.; Wilson, D.; Labruère, C.; Bonnin, A.; Hube, B. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell. Microbiol., 2010, 12, 248-271.
-
(2010)
Cell. Microbiol.
, vol.12
, pp. 248-271
-
-
Dalle, F.1
Wächtler, B.2
L'Ollivier, C.3
Holland, G.4
Bannert, N.5
Wilson, D.6
Labruère, C.7
Bonnin, A.8
Hube, B.9
-
138
-
-
0030749898
-
Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats
-
De Bernardis, F.; Boccanera, M.; Adriani, D.; Spreghini, E.; Santoni, G.; Cassone, A. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun., 1997, 65, 3399-3405. (Pubitemid 27342428)
-
(1997)
Infection and Immunity
, vol.65
, Issue.8
, pp. 3399-3405
-
-
De Bernardis, F.1
Boccanera, M.2
Adriani, D.3
Spreghini, E.4
Santoni, G.5
Cassone, A.6
-
139
-
-
0025032294
-
Modulation of experimental systemic murine candidosis by intravenous pepstatin
-
Rüchel, R.; Ritter, B.; Schaffrinski, M. Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentralbl. Bakteriol. 1990, 273, 391-403. (Pubitemid 20297919)
-
(1990)
Zentralblatt fur Bakteriologie
, vol.273
, Issue.3
, pp. 391-403
-
-
Ruchel, R.1
Ritter, B.2
Schaffrinski, M.3
-
140
-
-
0025097124
-
Effect of pepstatin A on Candida albicans infection in the mouse
-
Zotter, C.; Haustein, U.F.; Schönborn, C.; Grimmecke, H.D.; Wand, H. Effect of pepstatin A on Candida albicans infection in the mouse. Dermatol. Monatsschr., 1990, 176, 189-198.
-
(1990)
Dermatol. Monatsschr.
, vol.176
, pp. 189-198
-
-
Zotter, C.1
Haustein, U.F.2
Schönborn, C.3
Grimmecke, H.D.4
Wand, H.5
-
141
-
-
0031037510
-
Role of aspartic proteases in disseminated Candida albicans infection in mice
-
Fallon, K.; Bausch, K.; Noonan, J.; Huguenel, E.; Tamburini, P. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun., 1997, 65, 551-556. (Pubitemid 27053224)
-
(1997)
Infection and Immunity
, vol.65
, Issue.2
, pp. 551-556
-
-
Fallon, K.1
Bausch, K.2
Noonan, J.3
Huguenel, E.4
Tamburini, P.5
-
142
-
-
0023949895
-
Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent
-
Edison, A.M.; Manning-Zweerink, M. Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent. Infect. Immun., 1988, 56, 1388-1390.
-
(1988)
Infect. Immun.
, vol.56
, pp. 1388-1390
-
-
Edison, A.M.1
Manning-Zweerink, M.2
-
143
-
-
0037727675
-
Aspartic peptidase inhibitors: Implications in drug development
-
Dash, C.; Kulkarni, A.; Dunn, B.; Rao, M. Aspartic peptidase inhibitors: implications in drug development. Crit. Rev. Biochem. Mol. Biol., 2003, 38, 89-119. (Pubitemid 36571002)
-
(2003)
Critical Reviews in Biochemistry and Molecular Biology
, vol.38
, Issue.2
, pp. 89-119
-
-
Dash, C.1
Kulkarni, A.2
Dunn, B.3
Rao, M.4
-
145
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA panel
-
Carpenter, C.C.J.; Cooper, D.A.; Fischl, M.A.; Gatell, J.M.; Gazzard, B.G.; Hammer, S.M.; Hirsch, M.S.; Jacobsen, D.M.; Katzenstein, D.A.; Montaner, J.S.G.; Richman, D.D.; Saag, M.S.; Schechter, M.; Schooley, R.T.; Thompson, M.A.; Vella, S.; Yeni, P.G.; Volberding, P.A. Antiretroviral therapy in adults: updated recommendations of the international AIDS society-USA panel. JAMA, 2000, 283, 381-390. (Pubitemid 30051757)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.3
, pp. 381-390
-
-
Carpenter, C.C.J.1
Cooper, D.A.2
Fischl, M.A.3
Gatell, J.M.4
Gazzard, B.G.5
Hammer, S.M.6
Hirsch, M.S.7
Jacobsen, D.M.8
Katzenstein, D.A.9
Montaner, J.S.G.10
Richman, D.D.11
Saag, M.S.12
Schechter, M.13
Schooley, R.T.14
Thompson, M.A.15
Vella, S.16
Yeni, P.G.17
Volberding, P.A.18
-
146
-
-
0029941855
-
Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir [6]
-
DOI 10.1056/NEJM199606203342515
-
Zingman, B.S. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N. Engl. J. Med., 1996, 334, 1674-1675. (Pubitemid 26192535)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.25
, pp. 1674-1675
-
-
Zingman, B.S.1
-
147
-
-
0031774662
-
HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: A 2-year study
-
Hoegl, L.; Thoma-Greber, E.; Röcken, M.; Korting, H.C. HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: results of a study over a period of 2 years. Mycoses, 1998, 41, 321- 325. (Pubitemid 28553053)
-
(1998)
Mycoses
, vol.41
, Issue.7-8
, pp. 321-325
-
-
Hoegl, L.1
Thoma-Greber, E.2
Rocken, M.3
Korting, H.C.4
-
148
-
-
0033135992
-
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: A prospective case-control study
-
Cauda, R.; Tacconelli, E.; Tumbarello, M.; Morace, G.; De Bernardis, F.; Torosantucci, A.; Cassone, A. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective casecontrol study. J. Aquir. Immune Def. Syndr., 1999, 21, 20-25. (Pubitemid 29214320)
-
(1999)
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
, vol.21
, Issue.1
, pp. 20-25
-
-
Cauda, R.1
Tacconelli, E.2
Tumbarello, M.3
Morace, G.4
De Bernardis, F.5
Torosantucci, A.6
Cassone, A.7
-
149
-
-
0036816362
-
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
-
Babiker, A.; Darbyshire, J.; Pezzotti, P.; Porter, K.; Rezza, G.; Walker, S.A.; Beral, V.; Coutinho, R.; Del Amo, J.; Gill, N.; Lee, C.; Meyer, L.; Tyrer, F.; Dabis, F.; Thiebaut, R.; Lawson-Aye, S.; Boufassa, F.; Hamouda, O.; Fischer, K.; Rezza, G.; Touloumi, G.; Hatzakis, A.; Karafoulidou, A.; Katsarou, O.; Brettle, R.; del Romero, J.; Prins, M.; van Benthem, B.; Kirk, O.; Pederson, C.; Hernández, A.I.; Pérez-Hoyos, S.; Eskild, A.; Bruun, J.N.; Sannes, M.; Sabin, C.; Lee, C.; Johnson, A.M.; Phillips, A.N.; Francioli, P.; Vanhems, P.; Egger, M.; Rickenbach, M.; Cooper, D.; Kaldor, J.; Ashton, L.; Vizzard, J.; Muga, R.; Day, N.E. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int. J. Epidemiol., 2002, 31, 951-958. (Pubitemid 35446867)
-
(2002)
International Journal of Epidemiology
, vol.31
, Issue.5
, pp. 951-958
-
-
Babiker, A.1
Darbyshire, J.2
Pezzotti, P.3
Porter, K.4
Rezza, G.5
Walker, A.S.6
Beral, V.7
Coutinho, R.8
Del Amo, J.9
Gill, N.10
Lee, C.11
Meyer, L.12
Rezza, G.13
Tyrer, F.14
Dabis, F.15
Thiebaut, R.16
Lawson-Aye, S.17
Meyer, L.18
Boufassa, F.19
Hamouda, O.20
Fischer, K.21
Touloumi, G.22
Hatzakis, A.23
Karafoulidou, A.24
Katsarou, O.25
Brettle, R.26
Del Amo, J.27
Del Romero, J.28
Prins, M.29
Coutinho, R.A.30
Van Benthem, B.31
Kirk, O.32
Pedersen, C.33
Hernandez Aguado, I.34
Perez-Hoyos, S.35
Eskild, A.36
Bruun, J.N.37
Sannes, M.38
Sabin, C.39
Johnson, A.M.40
Phillips, A.N.41
Darbyshire, J.H.42
Francioli, P.43
Vanhems, P.44
Egger, M.45
Riekenbach, M.46
Cooper, D.47
Kaldor, J.48
Ashton, L.49
Vissard, J.50
Muga, R.51
Day, N.E.52
De Angelis, D.53
more..
-
150
-
-
0028874048
-
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
-
Ho, D.D.; Neumann, A.U.; Perelson, A.S.; Chen, W.; Leonard, J.M.; Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 1995, 373, 123-126.
-
(1995)
Nature
, vol.373
, pp. 123-126
-
-
Ho, D.D.1
Neumann, A.U.2
Perelson, A.S.3
Chen, W.4
Leonard, J.M.5
Markowitz, M.6
-
151
-
-
0030868897
-
+ T cell homeostasis and function in advanced HIV disease
-
DOI 10.1126/science.277.5322.112
-
Autran, B.; Carcelain, G.; Li, T.S.; Blanc, C.; Mathez, D.; Tubiana, R.; Katlama, C.; Debré, P.; Leibowitch, J. Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease. Science, 1997, 277, 112-116. (Pubitemid 27450659)
-
(1997)
Science
, vol.277
, Issue.5322
, pp. 112-116
-
-
Autran, B.1
Carcelain, G.2
Li, T.S.3
Blanc, C.4
Mathez, D.5
Tubiana, R.6
Katlama, C.7
Debre, P.8
Leibowitch, J.9
-
152
-
-
0032732511
-
HAART in HIV-infected patients: Restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia
-
DOI 10.1097/00002030-199910010-00007
-
Wendland, T.; Furrer, H.; Vernazza, P.L.; Frutig, K.; Christen, A.; Matter, L.; Malinverni, R.; Pichler, W.J. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS, 1999, 13, 1857-1862. (Pubitemid 29509544)
-
(1999)
AIDS
, vol.13
, Issue.14
, pp. 1857-1862
-
-
Wendland, T.1
Furrer, H.2
Vernazza, P.L.3
Frutig, K.4
Christen, A.5
Matter, L.6
Malinverni, R.7
Pichler, W.J.8
-
153
-
-
0033007068
-
Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients
-
DOI 10.1097/00002030-199905280-00003
-
Mastroianni, C.M.; Lichtner, M.; Mengoni, F.; D'Agostino, C.; Forcina, G.; d'Ettorre, G.; Santopadre, P.; Vullo, V. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1- infected patients. AIDS, 1999, 13, 883-890. (Pubitemid 29240182)
-
(1999)
AIDS
, vol.13
, Issue.8
, pp. 883-890
-
-
Mastroianni, C.M.1
Lichtner, M.2
Mengoni, F.3
D'Agostino, C.4
Forcina, G.5
D'Ettorre, G.6
Santopadre, P.7
Vullo, V.8
-
154
-
-
0035880249
-
The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIVinfected and uninfected individuals
-
Chavan, S.; Kodoth, S.; Pahwa, R.; Pahwa, S. The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIVinfected and uninfected individuals. Blood, 2001, 98, 383-389.
-
(2001)
Blood
, vol.98
, pp. 383-389
-
-
Chavan, S.1
Kodoth, S.2
Pahwa, R.3
Pahwa, S.4
-
155
-
-
0035883068
-
Antiapoptotic mechanism of HIV protease inhibitors: Preventing mitochondrial transmembrane potential loss
-
Phenix, B.N.; Lum, J.J.; Nie, Z.; Sanchez-Dardon, J.; Badley, A.D. Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood, 2001, 98, 1078-1085.
-
(2001)
Blood
, vol.98
, pp. 1078-1085
-
-
Phenix, B.N.1
Lum, J.J.2
Nie, Z.3
Sanchez-Dardon, J.4
Badley, A.D.5
-
156
-
-
0037093067
-
Antitumorigenic effects of HIV protease inhibitor ritonavir: Inhibition of kaposi sarcoma
-
DOI 10.1182/blood.V99.10.3771
-
Pati, S.; Pelser, C.B.; Dufraine, J.; Bryant, J.L.; Reitz, M.S.Jr.; Weichold, F.F. Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma. Blood, 2002, 99, 3771-3779. (Pubitemid 34534550)
-
(2002)
Blood
, vol.99
, Issue.10
, pp. 3771-3779
-
-
Pati, S.1
Pelser, C.B.2
Dufraine, J.3
Bryant, J.L.4
Reitz Jr., M.S.5
Weichold, F.F.6
-
157
-
-
46949104143
-
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity
-
DOI 10.1189/jlb.0707454
-
Pericolini, E.; Cenci, E.; Gabrielli, E.; Perito, S.; Mosci, P.; Bistoni, F.; Vecchiarelli, A. Indinavir influences biological function of dendritic cells and stimulates antifungal immunity. J. Leukoc. Biol., 2008, 83, 1286-1294. (Pubitemid 351960361)
-
(2008)
Journal of Leukocyte Biology
, vol.83
, Issue.5
, pp. 1286-1294
-
-
Pericolini, E.1
Cenci, E.2
Gabrielli, E.3
Perito, S.4
Mosci, P.5
Bistoni, F.6
Vecchiarelli, A.7
-
158
-
-
0036605931
-
Human immunodeficiency virus protease inhibitors and Pneumocystis carinii
-
Atzori, C.; Cargnel, A. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii. J. Infect. Dis., 2002, 185, 1692-1693.
-
(2002)
J. Infect. Dis.
, vol.185
, pp. 1692-1693
-
-
Atzori, C.1
Cargnel, A.2
-
159
-
-
4444310392
-
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans
-
DOI 10.1016/j.femsim.2004.05.001, PII S0928824404000884
-
Blasi, E.; Colombari, B.; Orsi, C.F.; Pinti, M.; Troiano, L.; Cossarizza, A.; Esposito, R.; Peppoloni, S.; Mussini, C.; Neglia, R. The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans. FEMS Immunol. Med. Microbiol., 2004, 42, 187-195. (Pubitemid 39208546)
-
(2004)
FEMS Immunology and Medical Microbiology
, vol.42
, Issue.2
, pp. 187-195
-
-
Blasi, E.1
Colombari, B.2
Francesca Orsi, C.3
Pinti, M.4
Leonarda Troiano5
Cossarizza, A.6
Esposito, R.7
Peppoloni, S.8
Mussini, C.9
Neglia, R.10
-
160
-
-
11844285691
-
Influence of indinavir on virulence and growth of Cryptococcus neoformans
-
DOI 10.1086/426828
-
Monari, C.; Pericolini, E.; Bistoni, G.; Cenci, E.; Bistoni, F.; Vecchiarelli, A. Influence of indinavir on virulence and growth of Cryptococcus neoformans. J. Infect. Dis., 2005, 191, 307-311. (Pubitemid 40096390)
-
(2005)
Journal of Infectious Diseases
, vol.191
, Issue.2
, pp. 307-311
-
-
Monari, C.1
Pericolini, E.2
Bistoni, G.3
Cenci, E.4
Bistoni, F.5
Vecchiarelli, A.6
-
161
-
-
33751368021
-
Detection of HIV protease inhibitors in alveolar epithelial lining fluid: Relevance for modulation of Pneumocystis infection in the course of HAART
-
DOI 10.1111/j.1550-7408.2006.00206.x
-
Atzori, C.; Villani, P.; Regazzi, M.; Mazza, F.; Valerio, A.; Tronconi, E.; Maruzzi, M.; Cargnel, A. Detection of HIV protease inhibitors in alveolar epithelial lining fluid: relevance for modulation of pneumocystis infection in the course of HAART. J. Eukaryot. Microbiol., 2006, 53, S140-S141. (Pubitemid 44813362)
-
(2006)
Journal of Eukaryotic Microbiology
, vol.53
, Issue.SUPPL. 1
-
-
Atzori, C.1
Villani, P.2
Regazzi, M.3
Mazza, F.4
Valerio, A.5
Tronconi, E.6
Maruzzi, M.7
Cargnel, A.8
-
162
-
-
33749859007
-
Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: Effect of HIV aspartyl proteolytic inhibitors
-
DOI 10.1016/j.resmic.2006.07.003, PII S0923250806001513
-
Palmeira, V.F.; Kneipp, L.F.; Alviano, C.S.; Santos, A.L.S. Secretory aspartyl peptidase from mycelia of Fonsecaea pedrosoi: effect of HIV peptidase inhibitors. Res. Microbiol., 2006, 157, 819-826. (Pubitemid 44559672)
-
(2006)
Research in Microbiology
, vol.157
, Issue.9
, pp. 819-826
-
-
Palmeira, V.F.1
Kneipp, L.F.2
Alviano, C.S.3
Dos Santos, A.L.S.4
-
163
-
-
54449083055
-
Beneficial effects of HIV aspartyl peptidase inhibitors on the human pathogen Fonsecaea pedrosoi: Promising compounds to arrest key fungal biological process and virulence
-
Palmeira, V.F.; Kneipp, L.F.; Rozental, S.; Alviano, C.S.; Santos, A.L.S. Beneficial effects of HIV aspartyl peptidase inhibitors on the human pathogen Fonsecaea pedrosoi: promising compounds to arrest key fungal biological process and virulence. PLoS ONE, 2008, 3, e3382.
-
(2008)
PLoS ONE
, vol.3
-
-
Palmeira, V.F.1
Kneipp, L.F.2
Rozental, S.3
Alviano, C.S.4
Santos, A.L.S.5
-
164
-
-
31344449267
-
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts
-
DOI 10.1080/13693780500252020, PII L486573892711
-
Pericolini, E.; Cenci, E.; Monari, C.; Perito, S.; Mosci, P.; Bistoni, G.; Vecchiarelli, A. Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts. Med. Mycol., 2006, 44, 119-126. (Pubitemid 43135538)
-
(2006)
Medical Mycology
, vol.44
, Issue.2
, pp. 119-126
-
-
Pericolini, E.1
Cenci, E.2
Monari, C.3
Perito, S.4
Mosci, P.5
Bistoni, G.6
Vecchiarelli, A.7
-
165
-
-
37149042967
-
Tipranavir exhibits different effects on opportunistic pathogenic fungi
-
DOI 10.1016/j.jinf.2007.08.004, PII S0163445307007323
-
Cenci, E.; Francisci, D.; Belfiori, B.; Pierucci, S.; Baldelli, F.; Bistoni, F.; Vecchiarelli, A. Tipranavir exhibits different effects on opportunistic pathogenic fungi. J. Infect., 2008, 56, 58-64. (Pubitemid 350258320)
-
(2008)
Journal of Infection
, vol.56
, Issue.1
, pp. 58-64
-
-
Cenci, E.1
Francisci, D.2
Belfiori, B.3
Pierucci, S.4
Baldelli, F.5
Bistoni, F.6
Vecchiarelli, A.7
-
166
-
-
79957966128
-
Aspartic peptidase inhibitors as potential bioactive pharmacological compounds against human fungal pathogens
-
Ahmad, I.; Owais, M.; Shahid, M.; Aqil, F., Eds.; Springer-Verlag, Germany
-
Santos, A.L.S. Aspartic peptidase inhibitors as potential bioactive pharmacological compounds against human fungal pathogens. In: Combating fungal infections: problems and remedy, Ahmad, I.; Owais, M.; Shahid, M.; Aqil, F., Eds.; Springer-Verlag, Germany, 2010; pp. 289-326.
-
(2010)
Combating Fungal Infections: Problems and Remedy
, pp. 289-326
-
-
Santos, A.L.S.1
-
167
-
-
0032580479
-
HIV-protease inhibitors
-
DOI 10.1056/NEJM199804303381808
-
Flexner, C, HIV-protease inhibitors. N. Engl. J. Med., 1998, 338, 1281-1292. (Pubitemid 28216584)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.18
, pp. 1281-1292
-
-
Flexner, C.1
-
168
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
DOI 10.1056/NEJM199803263381301
-
Palella, F.J.Jr.; Delaney, K.M.; Moorman. A.C.; Loveless, M.O.; Fuhrer, J.; Satten, G.A.; Aschman, D.J.; Holmberg, S.D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N. Engl. J. Med., 1998, 338, 853-860. (Pubitemid 28135961)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella Jr., F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
Aschman, D.J.7
Holmberg, S.D.8
-
169
-
-
0842305127
-
Social support and quality of life over time among adults living with HIV in the HAART era
-
DOI 10.1016/S0277-9536(03)00314-9
-
Burgoyne, R.; Renwick, R. Social support and quality of life over time among adults living with HIV in the HAART era. Soc. Sci. Med., 2004, 58, 1353-1366. (Pubitemid 38169337)
-
(2004)
Social Science and Medicine
, vol.58
, Issue.7
, pp. 1353-1366
-
-
Burgoyne, R.1
Renwick, R.2
-
170
-
-
40049101860
-
Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act
-
DOI 10.1093/jac/dkm499
-
Burgoyne, R.W.; Tan, D.H. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act. J. Antimicrob. Chemother., 2008, 61, 469-473. (Pubitemid 351321116)
-
(2008)
Journal of Antimicrobial Chemotherapy
, vol.61
, Issue.3
, pp. 469-473
-
-
Burgoyne, R.W.1
Tan, D.H.S.2
-
171
-
-
22144494164
-
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART
-
DOI 10.1080/09540120412331319714
-
Jelsma, J.; MacLean, E.; Hughes, J.; Tinise, X.; Darder, M. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care, 2005, 17, 579-588. (Pubitemid 40979466)
-
(2005)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
, vol.17
, Issue.5
, pp. 579-588
-
-
Jelsma, J.1
Maclean, E.2
Hughes, J.3
Tinise, X.4
Darder, M.5
-
172
-
-
77649310250
-
Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: A systematic literature review
-
Beard, J.; Feeley, F.; Rosen, S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care, 2009, 21, 1343-1356.
-
(2009)
AIDS Care
, vol.21
, pp. 1343-1356
-
-
Beard, J.1
Feeley, F.2
Rosen, S.3
-
173
-
-
4444317560
-
Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors
-
DOI 10.1016/j.tripleo.2004.05.017, PII S1079210404003543
-
Migliorati, C.A.; Birman, E.G.; Cury, A.E. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2004, 98, 301-310. (Pubitemid 39200696)
-
(2004)
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
, vol.98
, Issue.3
, pp. 301-310
-
-
Migliorati, C.A.1
Birman, E.G.2
Cury, A.E.3
-
174
-
-
61449189645
-
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
-
De Clercq, E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int. J. Antimicrob. Agents, 2009, 33, 307-320.
-
(2009)
Int. J. Antimicrob. Agents
, vol.33
, pp. 307-320
-
-
De Clercq, E.1
-
175
-
-
0032728881
-
HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases
-
Borg-von Zepelin, M.; Meyer. I.; Thomssen, R.; Würzner, R.; Sanglard, D.; Telenti, A.; Monod, M. HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J. Invest. Dermatol., 1999, 113, 747-751.
-
(1999)
J. Invest. Dermatol.
, vol.113
, pp. 747-751
-
-
Borg-Von Zepelin, M.1
Meyer, I.2
Thomssen, R.3
Würzner, R.4
Sanglard, D.5
Telenti, A.6
Monod, M.7
-
176
-
-
0033509027
-
In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors
-
DOI 10.1086/314871
-
Cassone, A.; De Bernardis, F.; Torosantucci, A.; Tacconelli, E.; Tumbarello, M.; Cauda, R. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis., 1999, 180, 448- 453. (Pubitemid 30256327)
-
(1999)
Journal of Infectious Diseases
, vol.180
, Issue.2
, pp. 448-453
-
-
Cassone, A.1
De Bernardis, F.2
Torosantucci, A.3
Tacconelli, E.4
Tumbarello, M.5
Cauda, R.6
-
177
-
-
0033017934
-
Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro
-
DOI 10.1016/S0162-3109(99)00035-1, PII S0162310999000351
-
Gruber, A.; Speth, C.; Lukasser-Vogl, E.; Zangerle, R.; Borg-von Zepelin, M.; Dierich, M.P.; Würzner, R. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology, 1999, 41, 227-234. (Pubitemid 29243825)
-
(1999)
Immunopharmacology
, vol.41
, Issue.3
, pp. 227-234
-
-
Gruber, A.1
Speth, C.2
Lukasser-Vogl, E.3
Zangerle, R.4
Borg-Von Zepelin, M.5
Dierich, M.P.6
Wurzner, R.7
-
178
-
-
0032851567
-
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors
-
Gruber, A.; Berlit, J.; Speth, C.; Lass-Flörl, C.; Kofler, G.; Nagl, M.; Borgvon Zepelin, M.; Dierich, M.P.; Würzner, R. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology, 1999, 201, 133-144. (Pubitemid 29457306)
-
(1999)
Immunobiology
, vol.201
, Issue.1
, pp. 133-144
-
-
Gruber, A.1
Berlit, J.2
Speth, C.3
Lass-Florl, C.4
Kofler, G.5
Nagl, M.6
Zepelin, M.B.-V.7
Dierich, M.P.8
Wurzner, R.9
-
179
-
-
0032873005
-
Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients
-
Korting, H.C.; Schaller, M.; Eder, G.; Hamm, G.; Böhmer, U.; Hube, B. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob. Agents Chemother., 1999, 43, 2038-2042. (Pubitemid 29395205)
-
(1999)
Antimicrobial Agents and Chemotherapy
, vol.43
, Issue.8
, pp. 2038-2042
-
-
Korting, H.C.1
Schaller, M.2
Eder, G.3
Hamm, G.4
Bohmer, U.5
Hube, B.6
-
180
-
-
0037341639
-
Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans
-
DOI 10.1099/jmm.0.05048-0
-
Schaller, M.; Krnjaic, N.; Niewerth, M.; Hamm, G.; Hube, B.; Korting, H.C. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans. J. Med. Microbiol., 2003, 52, 247-249. (Pubitemid 36324212)
-
(2003)
Journal of Medical Microbiology
, vol.52
, Issue.3
, pp. 247-249
-
-
Schaller, M.1
Krnjaic, N.2
Niewerth, M.3
Hamm, G.4
Hube, B.5
Korting, H.C.6
-
181
-
-
76349109672
-
Multiple effects of amprenavir against Candida albicans
-
Braga-Silva, L.A.; Mogami, S.S.; Valle, R.S.; Silva-Neto, I.D.; Santos, A.L.S. Multiple effects of amprenavir against Candida albicans. FEMS Yeast Res., 2010, 10, 221-224.
-
(2010)
FEMS Yeast Res.
, vol.10
, pp. 221-224
-
-
Braga-Silva, L.A.1
Mogami, S.S.2
Valle, R.S.3
Silva-Neto, I.D.4
Santos, A.L.S.5
-
182
-
-
0142090933
-
Heterogeneity of metallo and serine extracellular proteinases in oral clinical isolates of Candida albicans in HIV-positive and healthy children from Rio de Janeiro, Brazil
-
DOI 10.1016/S0928-8244(03)00145-7
-
Costa, E.M.M.B.; Santos, A.L.S.; Cardoso, A.S.; Portela, M.B.; Abreu, C.M.; Alviano, C.S.; Hagler, N.A.; Soares, R.M.A. Heterogeneity of metallo and serine extracellular proteinases in oral clinical isolates of Candida albicans in HIV-positive and healthy children from Rio de Janeiro, Brazil. FEMS Immunol. Med. Microbiol., 2003, 38, 173-180. (Pubitemid 37297843)
-
(2003)
FEMS Immunology and Medical Microbiology
, vol.38
, Issue.2
, pp. 173-180
-
-
Costa, E.M.M.D.B.1
Dos Santos, A.L.S.2
Cardoso, A.S.3
Portela, M.B.4
Abreu, C.M.5
Alviano, C.S.6
Hagler, A.N.7
Soares, R.M.D.A.8
-
183
-
-
11144328093
-
Candida guilliermondii isolated from HIV-infected human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous substrates
-
DOI 10.1016/j.femsim.2004.06.022, PII S0928824404001403
-
Santos, A.L.S.; Soares, R.M.A. Candida guilliermondii isolated from HIVinfected human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous substrates. FEMS Immunol. Med. Microbiol., 2005, 43, 13-20. (Pubitemid 40029422)
-
(2005)
FEMS Immunology and Medical Microbiology
, vol.43
, Issue.1
, pp. 13-20
-
-
Dos Santos, A.L.S.1
Soares, R.M.D.A.2
-
184
-
-
33645083460
-
Secretion of serine peptidase by a clinical strain of Candida albicans: Influence of growth conditions and cleavage of human serum proteins and extracellular matrix components
-
Santos, A.L.S.; Carvalho, I.M.; Silva, B.A.; Portela, M.B.; Alviano, C.S.; Soares, R.M.A. Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components. FEMS Immunol. Med. Microbiol., 2006, 46, 209-220.
-
(2006)
FEMS Immunol. Med. Microbiol.
, vol.46
, pp. 209-220
-
-
Santos, A.L.S.1
Carvalho, I.M.2
Silva, B.A.3
Portela, M.B.4
Alviano, C.S.5
Soares, R.M.A.6
-
185
-
-
77958585305
-
Effect of serine-type protease inhibitor on Candida spp. isolated from linear gingival erythema of HIVpositive children: Critical factors in the colonization
-
Portela, M.B.; Souza, I.P.R.; Abreu, C.M.; Bertolini, M.; Holandino, C.; Alviano, C.S.; Santos, A.L.S.; Soares, R.M.A. Effect of serine-type protease inhibitor on Candida spp. isolated from linear gingival erythema of HIVpositive children: critical factors in the colonization. J. Oral Pathol. Med., 2010, 39, 753-760.
-
(2010)
J. Oral Pathol. Med.
, vol.39
, pp. 753-760
-
-
Portela, M.B.1
Souza, I.P.R.2
Abreu, C.M.3
Bertolini, M.4
Holandino, C.5
Alviano, C.S.6
Santos, A.L.S.7
Soares, R.M.A.8
-
186
-
-
0032727035
-
Failure of indinavir to inhibit Candida albicans in vitro
-
Diz, P.; Otero, I.; Iglesias, I.; Ocampo, A.; Martínez, C. Failure of indinavir to inhibit Candida albicans in vitro. Eur. J. Clin. Microbiol. Infect. Dis., 1999, 18, 755-756.
-
(1999)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.18
, pp. 755-756
-
-
Diz, P.1
Otero, I.2
Iglesias, I.3
Ocampo, A.4
Martínez, C.5
-
187
-
-
0344889212
-
Lack of ritonavir antifungal effect in vitro [2]
-
Diz, P.; Ocampo, A.; Iglesias, I.; Otero, I. Lack of ritonavir antifungal effect in vitro. Antimicrob. Agents Chemother., 1999, 43, 997. (Pubitemid 29165781)
-
(1999)
Antimicrobial Agents and Chemotherapy
, vol.43
, Issue.4
, pp. 997
-
-
Diz, P.1
Ocampo, A.2
Iglesias, I.3
Otero, I.4
-
188
-
-
0028958769
-
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method
-
Gehrt, A.; Peter, J.; Pizzo, P.A.; Walsh, T.J. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol., 1995, 33, 1302-1307.
-
(1995)
J. Clin. Microbiol.
, vol.33
, pp. 1302-1307
-
-
Gehrt, A.1
Peter, J.2
Pizzo, P.A.3
Walsh, T.J.4
-
189
-
-
0037334425
-
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method
-
DOI 10.1016/S0924-8579(02)00189-9, PII S0924857902001899
-
Lass-Flörl, C.; Speth, C.; Kofler, G.; Dierch, M.P.; Gunsilius, E.; Würzner, R. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method. Int. J. Antimicrob. Agents, 2003, 21, 229-233. (Pubitemid 36299183)
-
(2003)
International Journal of Antimicrobial Agents
, vol.21
, Issue.3
, pp. 229-233
-
-
Lass-Florl, C.1
Speth, C.2
Kofler, G.3
Dierch, M.P.4
Gunsilius, E.5
Wurzner, R.6
-
190
-
-
0031686839
-
Molecular and biotechnological aspects of microbial proteases
-
Rao, M.B.; Tanksale, A.M.; Ghatge, M.S.; Deshpande, V.V. Molecular and biotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev., 1998, 62, 597-635. (Pubitemid 28415546)
-
(1998)
Microbiology and Molecular Biology Reviews
, vol.62
, Issue.3
, pp. 597-635
-
-
Rao, M.B.1
Tanksale, A.M.2
Ghatge, M.S.3
Deshpande, V.V.4
-
191
-
-
79957938315
-
Protease expression by microorganisms and its relevance to crucial physiological/pathological events
-
Santos, A.L.S. Protease expression by microorganisms and its relevance to crucial physiological/pathological events. World J. Biol. Chem., 2011, 2, 48- 58.
-
(2011)
World J. Biol. Chem.
, vol.2
, pp. 48-58
-
-
Santos, A.L.S.1
-
192
-
-
0034507448
-
Fungal morphogenesis and virulence
-
San-Blas, G.; Travassos, L.R.; Fries, B.C.; Goldman, D.L.; Casadevall, A.; Carmona, A.K.; Barros, T.F.; Puccia, R.; Hostetter, M.K.; Shanks, S.G.; Copping, V.M.; Knox, Y.; Gow, N.A. Fungal morphogenesis and virulence. Med. Mycol., 2000, 38, 79-86. (Pubitemid 32094057)
-
(2000)
Medical Mycology
, vol.38
, Issue.SUPPL. 1
, pp. 79-86
-
-
San-Blas, G.1
Travassos, L.R.2
Fries, B.C.3
Goldman, D.L.4
Casadevall, A.5
Carmona, A.K.6
Barros, T.F.7
Puccia, R.8
Hostetter, M.K.9
Shanks, S.G.10
Copping, V.M.S.11
Knox, Y.12
Gow, N.A.R.13
-
193
-
-
33751331633
-
Morphogenesis and cell cycle progression in Candida albicans
-
DOI 10.1016/j.mib.2006.10.007, PII S1369527406001597, Growth and Development
-
Berman, J. Morphogenesis and cell cycle progression in Candida albicans. Curr. Opin. Microbiol., 2006, 9, 595-601. (Pubitemid 44802999)
-
(2006)
Current Opinion in Microbiology
, vol.9
, Issue.6
, pp. 595-601
-
-
Berman, J.1
-
194
-
-
33644839600
-
Flocculation, adhesion and biofilm formation in yeasts
-
DOI 10.1111/j.1365-2958.2006.05072.x
-
Verstrepen, K.J.; Klis, F.M. Flocculation, adhesion and biofilm formation in yeasts. Mol. Microbiol., 2006, 60, 5-15. (Pubitemid 43363283)
-
(2006)
Molecular Microbiology
, vol.60
, Issue.1
, pp. 5-15
-
-
Verstrepen, K.J.1
Klis, F.M.2
-
195
-
-
2042519310
-
Candida Infections of Medical Devices
-
DOI 10.1128/CMR.17.2.255-267.2004
-
Kojic, E.M.; Darouiche, R.O. Candida infections of medical devices. Clin. Microbiol. Rev., 2004, 17, 255-267. (Pubitemid 38534029)
-
(2004)
Clinical Microbiology Reviews
, vol.17
, Issue.2
, pp. 255-267
-
-
Kojic, E.M.1
Darouiche, R.O.2
-
196
-
-
0034327420
-
Role of biofilms in antimicrobial resistance
-
Donlan, R.M. Role of biofilms in antimicrobial resistance. Asaio J., 2000, 46, S47-S52.
-
(2000)
Asaio J.
, vol.46
-
-
Donlan, R.M.1
-
197
-
-
0035029378
-
Biofilms and device-associated infections
-
Donlan, R.M. Biofilms and device-associated infections. Emerg. Infect. Dis., 2001, 7, 277-281. (Pubitemid 32374344)
-
(2001)
Emerging Infectious Diseases
, vol.7
, Issue.2
, pp. 277-281
-
-
Donlan, R.M.1
-
198
-
-
4143131048
-
Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns
-
DOI 10.1128/EC.3.2.536-545.2004
-
Garcia-Sanchez, S.; Aubert, S.; Iraqui, I.; Janbon, G.; Ghigo, J.M.; d'Enfert, C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell, 2004, 3, 536-545. (Pubitemid 38497991)
-
(2004)
Eukaryotic Cell
, vol.3
, Issue.2
, pp. 536-545
-
-
Garcia-Sanchez, S.1
Aubert, S.2
Iraqui, I.3
Janbon, G.4
Ghigo, J.-M.5
D'Enfert, C.6
-
199
-
-
34548655946
-
Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells
-
DOI 10.1248/bpb.30.1813
-
Mendes, A.; Moraes, A.U.; Carvalho, A.P.; Rosa, R.T.; Samaranayake, L.P.; Rosa, E.A. Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells. Biol. Pharm. Bull., 2007, 30, 1813-1815. (Pubitemid 47403267)
-
(2007)
Biological and Pharmaceutical Bulletin
, vol.30
, Issue.9
, pp. 1813-1815
-
-
Mendes, A.1
Mores, A.U.2
Carvalho, A.P.3
Rosa, R.T.4
Samaranayake, L.P.5
Rosa, E.A.R.6
-
200
-
-
77958101558
-
HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces
-
Tsang, C.S.; Hong, I. HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces. Mycoses, 2010, 53, 488-494.
-
(2010)
Mycoses
, vol.53
, pp. 488-494
-
-
Tsang, C.S.1
Hong, I.2
-
201
-
-
0036670881
-
Adhesion candida spp
-
Sundstrom, P. Adhesion in Candida spp. Cell. Microbiol., 2002, 4, 461-469.
-
(2002)
Cell. Microbiol.
, vol.4
, pp. 461-469
-
-
Sundstrom, P.1
-
202
-
-
2642696057
-
Cell wall and secreted proteins of Candida albicans: Identification, function, and expression
-
Chaffin, W.L.; López-Ribot, J.L.; Casanova, M.; Gozalbo, D.; Martínez, J.P. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev., 1998, 62, 130-180. (Pubitemid 28130799)
-
(1998)
Microbiology and Molecular Biology Reviews
, vol.62
, Issue.1
, pp. 130-180
-
-
Chaffin, W.L.1
Lopez-Ribot, J.L.2
Casanova, M.3
Gozalbo, D.4
Martinez, J.P.5
-
203
-
-
0034890629
-
HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro
-
DOI 10.1016/S0928-8244(01)00242-5, PII S0928824401002425
-
Bektič, J.; Lell, C.P.; Fuchs, A.; Stoiber, H.; Speth, C.; Lass-Flörl, C.; Borgvon Zepelin, M.; Dierich, M.P.; Würzner, R. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol. Med. Microbiol., 2001, 31, 65-71. (Pubitemid 32722002)
-
(2001)
FEMS Immunology and Medical Microbiology
, vol.31
, Issue.1
, pp. 65-71
-
-
Bektic, J.1
Lell, C.P.2
Fuchs, A.3
Stoiber, H.4
Speth, C.5
Lass-Florl, C.6
Borg-Von Zepelin, M.7
Dierich, M.P.8
Wurzner, R.9
-
204
-
-
34247610953
-
Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells
-
DOI 10.1111/j.1439-0507.2006.01353.x
-
Falkensammer, B.; Pilz, G.; Bektič, J.; Imwidthaya, P.; Jöhrer, K.; Speth, C.; Lass-Flörl, C.; Dierich, M.P.; Würzner, R. Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells. Mycoses, 2007, 50, 172-177. (Pubitemid 46683978)
-
(2007)
Mycoses
, vol.50
, Issue.3
, pp. 172-177
-
-
Falkensammer, B.1
Pilz, G.2
Bektic, J.3
Imwidthaya, P.4
Johrer, K.5
Speth, C.6
Lass-Florl, C.7
Dierich, M.P.8
Wurzner, R.9
-
205
-
-
0031971193
-
The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages
-
DOI 10.1046/j.1365-2958.1998.00815.x
-
Borg-von Zepelin, M.; Beggah, S.; Boggian, K.; Sanglard, D.; Monod, M. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol. Microbiol., 1998, 28, 543- 554. (Pubitemid 28218399)
-
(1998)
Molecular Microbiology
, vol.28
, Issue.3
, pp. 543-554
-
-
Borg-von Zepelin, M.1
Beggah, S.2
Boggian, K.3
Sanglard, D.4
Monod, M.5
-
206
-
-
0037080207
-
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects
-
DOI 10.1086/338445
-
Cassone, A.; Tacconelli, E.; De Bernardis, F.; Tumbarello, M.; Torosantucci, A.; Chiani, P.; Cauda, R. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J. Infect. Dis., 2002, 185, 188-195. (Pubitemid 34056442)
-
(2002)
Journal of Infectious Diseases
, vol.185
, Issue.2
, pp. 188-195
-
-
Cassone, A.1
Tacconelli, E.2
De Bernardis, F.3
Tumbarello, M.4
Torosantucci, A.5
Chiani, P.6
Cauda, R.7
-
207
-
-
0026631290
-
Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast
-
Mishra, P.; Bolard, J.; Prasad, R. Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast. Biochim. Biophys. Acta, 1992, 1127, 1-14.
-
(1992)
Biochim. Biophys. Acta
, vol.1127
, pp. 1-14
-
-
Mishra, P.1
Bolard, J.2
Prasad, R.3
-
208
-
-
70349527944
-
Lipid signaling in pathogenic fungi
-
Rhome, R.; Del Poeta, M. Lipid signaling in pathogenic fungi. Annu. Rev. Microbiol., 2009, 63, 119-131.
-
(2009)
Annu. Rev. Microbiol.
, vol.63
, pp. 119-131
-
-
Rhome, R.1
Del Poeta, M.2
-
209
-
-
35048890003
-
Recent advances in antifungal agents
-
DOI 10.2174/138955707781662672
-
Lóránd, T.; Kocsis, B. Recent advances in antifungal agents. Mini Rev. Med. Chem., 2007, 7, 900-911. (Pubitemid 47554780)
-
(2007)
Mini-Reviews in Medicinal Chemistry
, vol.7
, Issue.9
, pp. 900-911
-
-
Lorand, T.1
Kocsis, B.2
-
210
-
-
0033497821
-
Sialic acids in fungi: A minireview
-
DOI 10.1023/A:1007078106280
-
Alviano, C.S.; Travassos, L.R.; Schauer, R. Sialic acids in fungi: a minireview. Glycoconj. J., 1999, 16, 545-554. (Pubitemid 30168618)
-
(1999)
Glycoconjugate Journal
, vol.16
, Issue.9
, pp. 545-554
-
-
Alviano, C.S.1
Travassos, L.R.2
Schauer, R.3
-
211
-
-
0034611799
-
Identification of sialic acids on the cell surface of Candida albicans
-
DOI 10.1016/S0304-4165(00)00003-9, PII S0304416500000039
-
Soares, R.M.A.; de Araújo Soares, R.M.; Alviano, D.S.; Angluster, J.; Alviano, C.S.; Travassos, L.R. Identification of sialic acids on the cell surface of Candida albicans. Biochim. Biophys. Acta, 2000, 1474, 262-268. (Pubitemid 30165712)
-
(2000)
Biochimica et Biophysica Acta - General Subjects
, vol.1474
, Issue.2
, pp. 262-268
-
-
Soares, R.M.A.1
De, A.2
Soares, R.M.3
Alviano, D.S.4
Angluster, J.5
Alviano, C.S.6
Travassos, L.R.7
-
212
-
-
0034783753
-
Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells
-
DOI 10.1128/IAI.69.11.7091-7099.2001
-
Steele, C.; Leigh, J.; Swoboda, R.; Ozenci, H.; Fidel, P.L.Jr. Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect. Immun., 2001, 69, 7091-7099. (Pubitemid 32995470)
-
(2001)
Infection and Immunity
, vol.69
, Issue.11
, pp. 7091-7099
-
-
Steele, C.1
Leigh, J.2
Swoboda, R.3
Ozenci, H.4
Fidel Jr., P.L.5
-
213
-
-
0033302528
-
Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century
-
Walsh, T.J.; Groll, A.H. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl. Infect. Dis., 1999, 1, 247-261.
-
(1999)
Transpl. Infect. Dis.
, vol.1
, pp. 247-261
-
-
Walsh, T.J.1
Groll, A.H.2
-
214
-
-
0035889523
-
Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices
-
DOI 10.1086/323895
-
Singh, N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin. Infect. Dis., 2001, 33, 1692-1696. (Pubitemid 33044535)
-
(2001)
Clinical Infectious Diseases
, vol.33
, Issue.10
, pp. 1692-1696
-
-
Singh, N.1
-
215
-
-
0043162011
-
Antifungal activity of nonantifungal drugs
-
DOI 10.1007/s10096-003-0947-x
-
Afeltra, J.; Verweij, P.E. Antifungal activity of nonantifungal drugs. Eur. J. Clin. Microbiol., 2003, 22, 397-407. (Pubitemid 36963112)
-
(2003)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.22
, Issue.7
, pp. 397-407
-
-
Afeltra, J.1
Verweij, P.E.2
-
216
-
-
58849109341
-
Targeting virulence: A new paradigm for antifungals
-
Gauwerky, K.; Borelli, C.; Korting, H.C. Targeting virulence: a new paradigm for antifungals. Drug Discov. Today, 2009, 14, 214-222.
-
(2009)
Drug Discov. Today
, vol.14
, pp. 214-222
-
-
Gauwerky, K.1
Borelli, C.2
Korting, H.C.3
-
217
-
-
12844258859
-
Combination treatment of invasive fungal infections
-
DOI 10.1128/CMR.18.1.163-194.2005
-
Mukherjee, P.K.; Sheehan, D.J.; Hitchcock, C.A.; Ghannoum, M.A. Combination treatment of invasive fungal infections. Clin. Microbiol. Rev., 2005, 18, 163-194. (Pubitemid 40170667)
-
(2005)
Clinical Microbiology Reviews
, vol.18
, Issue.1
, pp. 163-194
-
-
Mukherjee, P.K.1
Sheehan, D.J.2
Hitchcock, C.A.3
Ghannoum, M.A.4
-
218
-
-
33748933537
-
Current status and future of antifungal therapy for systemic mycoses
-
Nosanchuk, J.D. Current status and future of antifungal therapy for systemic mycoses. Recent Patents Anti-Infect. Drug Disc., 2006, 1, 75-84.
-
(2006)
Recent Patents Anti-Infect. Drug Disc.
, vol.1
, pp. 75-84
-
-
Nosanchuk, J.D.1
-
219
-
-
67649604244
-
Toxicity of HIV protease inhibitors: Clinical considerations
-
Boesecke, C.; Cooper, D.A. Toxicity of HIV protease inhibitors: clinical considerations. Curr. Opin. HIV AIDS, 2008, 3, 653-659.
-
(2008)
Curr. Opin. HIV AIDS
, vol.3
, pp. 653-659
-
-
Boesecke, C.1
Cooper, D.A.2
-
220
-
-
6344280335
-
Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains
-
DOI 10.1016/j.phrs.2004.06.008, PII S1043661804001732
-
Casolari, C.; Rossi, T.; Baggio, G.; Coppi, A.; Zandomeneghi, G.; Ruberto, A.I.; Farina, C.; Fabio, G.; Zanca, A.; Castelli, M. Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains. Pharmacol. Res., 2004, 50, 605-610. (Pubitemid 39388971)
-
(2004)
Pharmacological Research
, vol.50
, Issue.6
, pp. 605-610
-
-
Casolari, C.1
Rossi, T.2
Baggio, G.3
Coppi, A.4
Zandomeneghi, G.5
Ruberto, A.I.6
Farina, C.7
Fabio, G.8
Zanca, A.9
Castelli, M.10
-
221
-
-
0038341642
-
Antifungal agents: Mechanisms of action
-
DOI 10.1016/S0966-842X(03)00117-3
-
Odds, F.C.; Brown, A.J.; Gow, N.A. Antifungal agents: mechanisms of action. Trends Microbiol., 2003, 11, 272-279. (Pubitemid 36725017)
-
(2003)
Trends in Microbiology
, vol.11
, Issue.6
, pp. 272-279
-
-
Odds, F.C.1
Brown, A.J.P.2
Gow, N.A.R.3
-
222
-
-
34347351025
-
Genomics and the development of new diagnostics and anti-Candida drugs
-
DOI 10.1016/j.tim.2007.05.007, PII S0966842X07001060
-
Weig, M.; Brown, A.J. Genomics and the development of new diagnostics and anti-Candida drugs. Trends Microbiol., 2007, 15, 310-317. (Pubitemid 47017714)
-
(2007)
Trends in Microbiology
, vol.15
, Issue.7
, pp. 310-317
-
-
Weig, M.1
Brown, A.J.P.2
-
225
-
-
0035521154
-
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets
-
DOI 10.1016/S1471-4922(01)02037-2, PII S1471492201020372
-
Coombs, G.H.; Goldberg, D.E.; Klemba, M.; Berry, C.; Kay, J.; Mottram, J.C. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol., 2001, 17, 532-537. (Pubitemid 34185360)
-
(2001)
Trends in Parasitology
, vol.17
, Issue.11
, pp. 532-537
-
-
Coombs, G.H.1
Goldberg, D.E.2
Klemba, M.3
Berry, C.4
Kay, J.5
Mottram, J.C.6
-
226
-
-
0034929770
-
Candida proteases and their inhibition: Prospects for antifungal therapy
-
Stewart, K.; Abad-Zapatero, C. Candida proteases and their inhibition: prospects for antifungal therapy. Curr. Med. Chem., 2001, 8, 941-948. (Pubitemid 32633552)
-
(2001)
Current Medicinal Chemistry
, vol.8
, Issue.8
, pp. 941-948
-
-
Stewart, K.1
Abad-Zapatero, C.2
-
227
-
-
0036218648
-
Aspartic proteinases in disease: A structural perspective
-
Cooper, J.B. Aspartic proteinases in disease: a structural perspective. Curr. Drug Targets, 2002, 3, 155-174.
-
(2002)
Curr. Drug Targets
, vol.3
, pp. 155-174
-
-
Cooper, J.B.1
-
228
-
-
0037038816
-
β-secretase (BACE) as a drug target for Alzheimer's disease
-
DOI 10.1016/S0169-409X(02)00157-6, PII S0169409X02001576
-
Vassar, R. Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv. Drug Deliv. Rev., 2002, 54, 1589-1602. (Pubitemid 35346833)
-
(2002)
Advanced Drug Delivery Reviews
, vol.54
, Issue.12
, pp. 1589-1602
-
-
Vassar, R.1
-
229
-
-
33845339435
-
Protease inhibitors in the clinic
-
Abbenante, G.; Fairlie, D.P. Protease inhibitors in the clinic. Med. Chem., 2005, 1, 71-104.
-
(2005)
Med. Chem.
, vol.1
, pp. 71-104
-
-
Abbenante, G.1
Fairlie, D.P.2
-
230
-
-
33745058715
-
Development in inhibitors of the aspartyl protease renin for the treatment of hypertension
-
DOI 10.2174/138920306777452330
-
Scott, B.B.; McGeehan, G.M.; Harrison, R.K. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension. Curr. Protein Pept. Sci., 2006, 7, 241-254. (Pubitemid 43881006)
-
(2006)
Current Protein and Peptide Science
, vol.7
, Issue.3
, pp. 241-254
-
-
Scott, B.B.1
-
231
-
-
50649106648
-
Cathepsin D-many functions of one aspartic protease
-
Benes, P.; Vetvicka, V.; Fusek, M. Cathepsin D-many functions of one aspartic protease. Crit. Rev. Oncol. Hematol., 2008, 68, 12-28.
-
(2008)
Crit. Rev. Oncol. Hematol.
, vol.68
, pp. 12-28
-
-
Benes, P.1
Vetvicka, V.2
Fusek, M.3
-
232
-
-
0035954861
-
Aspartic protease inhibitors designed from computer-generated templates bind as predicted
-
DOI 10.1021/ol016090+
-
Ripka, A.S.; Satyshur, K.A.; Bohacek, R.S.; Rich, D.H. Aspartic protease inhibitors designed from computer-generated templates bind as predicted. Org. Lett., 2001, 3, 2309-2312. (Pubitemid 33629492)
-
(2001)
Organic Letters
, vol.3
, Issue.15
, pp. 2309-2312
-
-
Ripka, A.S.1
Satyshur, K.A.2
Bohacek, R.S.3
Rich, D.H.4
-
233
-
-
0141888592
-
Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic proteases
-
DOI 10.1016/j.bmc.2003.08.004
-
Tossi, A.; Benedetti, F.; Norbedo, S.; Skrbec, D.; Berti, F.; Romeo, D. Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic proteases. Bioorg. Med. Chem., 2003, 11, 4719-4727. (Pubitemid 37230128)
-
(2003)
Bioorganic and Medicinal Chemistry
, vol.11
, Issue.22
, pp. 4719-4727
-
-
Tossi, A.1
Benedetti, F.2
Norbedo, S.3
Skrbec, D.4
Berti, F.5
Romeo, D.6
-
234
-
-
0036403057
-
Inhibition of Candida albicans secreted aspartic protease by a novel series of peptidomimetics, also active on the HIV-1 protease
-
DOI 10.1016/S0006-291X(02)02372-0, PII S0006291X02023720
-
Skrbec, D.; Romeo, D. Inhibition of Candida albicans secreted aspartic protease by a novel series of peptidomimetics, also active on the HIV-1 protease. Biochem. Biophys. Res. Commun., 2002, 297, 1350-1353. (Pubitemid 35216396)
-
(2002)
Biochemical and Biophysical Research Communications
, vol.297
, Issue.5
, pp. 1350-1353
-
-
Skrbec, D.1
Romeo, D.2
-
235
-
-
77949805994
-
Identification of inhibitors of drugresistant Candida albicans strains from a library of bicyclic peptidomimetic compounds
-
Trabocchi, A.; Mannino, C.; Machetti, F.; De Bernardis, F.; Arancia, S.; Cauda, R.; Cassone, A.; Guarna, A. Identification of inhibitors of drugresistant Candida albicans strains from a library of bicyclic peptidomimetic compounds. J. Med. Chem., 2010, 53, 2502-2509.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2502-2509
-
-
Trabocchi, A.1
Mannino, C.2
MacHetti, F.3
De Bernardis, F.4
Arancia, S.5
Cauda, R.6
Cassone, A.7
Guarna, A.8
-
236
-
-
0033214144
-
Synthesis and reactivity of bicycles derived from tartaric acid and -amino acids: A novel class of conformationally constrained dipeptide isosteres based upon enantiopure 3-aza-6,8- dioxabicyclo[3.2.1]octane-7-carboxylic acid
-
Guarna, A.; Guidi, A.; Machetti, F.; Menchi, G.; Occhiato, E.G.; Scarpi, D.; Sisi, S.; Trabocchi, A. Synthesis and reactivity of bicycles derived from tartaric acid and -amino acids: a novel class of conformationally constrained dipeptide isosteres based upon enantiopure 3-aza-6,8- dioxabicyclo[3.2.1]octane- 7-carboxylic acid. J Org. Chem., 1999, 64, 7347- 7364.
-
(1999)
J Org. Chem.
, vol.64
, pp. 7347-7364
-
-
Guarna, A.1
Guidi, A.2
MacHetti, F.3
Menchi, G.4
Occhiato, E.G.5
Scarpi, D.6
Sisi, S.7
Trabocchi, A.8
-
237
-
-
0012876039
-
Synthesis of new enantiopure bicyclic γ/δ-amino acid (BTKa) derived from tartaric acid and R-amino acetophenone
-
Guarna, A.; Bucelli, I.; Machetti, F.; Menchi, G.; Occhiato, E.G.; Scarpi, D.; Trabocchi, A. Synthesis of new enantiopure bicyclic γ/δ-amino acid (BTKa) derived from tartaric acid and R-amino acetophenone. Tetrahedron, 2002, 58, 9865-9870.
-
(2002)
Tetrahedron
, vol.58
, pp. 9865-9870
-
-
Guarna, A.1
Bucelli, I.2
MacHetti, F.3
Menchi, G.4
Occhiato, E.G.5
Scarpi, D.6
Trabocchi, A.7
-
238
-
-
0042709522
-
Enantiospecific synthesis of 3-aza-6,8-dioxa-bicyclo[3.2.1]octane carboxylic acids from erythrose
-
DOI 10.1016/S0040-4020(03)00773-7
-
Trabocchi, A.; Menchi, G.; Rolla, M.; Machetti, F.; Bucelli, I.; Guarna, A. Enantiospecific synthesis of 3-aza-6,8-dioxa-bicyclo-[3.2.1]octane carboxylic acids from erythrose. Tetrahedron, 2003, 59, 5251-5258. (Pubitemid 36929748)
-
(2003)
Tetrahedron
, vol.59
, Issue.28
, pp. 5251-5258
-
-
Trabocchi, A.1
Menchi, G.2
Rolla, M.3
Machetti, F.4
Bucelli, I.5
Guarna, A.6
-
239
-
-
0034762912
-
Phenolic compounds from Miconia myriantha inhibiting Candida aspartic proteases
-
DOI 10.1021/np010172p
-
Li, X.C.; Jacob, M.R.; Pasco, D.S.; ElSohly, H.N.; Nimrod, A.C.; Walker, L.A.; Clark, A.M. Phenolic compounds from Miconia myriantha inhibiting Candida aspartic proteases. J. Nat. Prod., 2001, 64, 1282-1285. (Pubitemid 33029207)
-
(2001)
Journal of Natural Products
, vol.64
, Issue.10
, pp. 1282-1285
-
-
Li, X.-C.1
Jacob, M.R.2
Pasco, D.S.3
ElSohly, H.N.4
Nimrod, A.C.5
Walker, L.A.6
Clark, A.M.7
-
241
-
-
0036329659
-
Natural products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cernuum
-
DOI 10.1021/np0200616
-
Zhang, Z.; ElSohly, H.N.; Jacob, M.R.; Pasco, D.S.; Walker, L.A.; Clark, A.M. Natural products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cernuum. J. Nat. Prod., 2002, 65, 979-985. (Pubitemid 34827482)
-
(2002)
Journal of Natural Products
, vol.65
, Issue.7
, pp. 979-985
-
-
Zhang, Z.1
ElSohly, H.N.2
Jacob, M.R.3
Pasco, D.S.4
Walker, L.A.5
Clark, A.M.6
-
242
-
-
53549084594
-
Design of potent aspartic protease inhibitors to treat various diseases
-
Nguyen, J.T.; Hamada, Y.; Kimura, T.; Kiso, Y. Design of potent aspartic protease inhibitors to treat various diseases. Arch. Pharm., 2008, 341, 523- 535.
-
(2008)
Arch. Pharm.
, vol.341
, pp. 523-535
-
-
Nguyen, J.T.1
Hamada, Y.2
Kimura, T.3
Kiso, Y.4
-
243
-
-
79957946472
-
-
US Patent No. 5,120,718, 1991, to Abbott Laboratories
-
Goldman, R.C.; Baker, W.R.; Jae, H.S.; De, B.; Zydowsky, T.M.; de Lara, E. US Patent No. 5,120,718, 1991, to Abbott Laboratories.
-
-
-
Goldman, R.C.1
Baker, W.R.2
Jae, H.S.3
De, B.4
Zydowsky, T.M.5
De Lara, E.6
-
244
-
-
79957962459
-
-
US Patent No. 5,164,388, to Abbott Laboratories, 1991
-
De, B.; Zydowsky, T.N.; Baker, W.R.; Dellaria, J.F.; Rosenberg, S.H.; Jae, H.S. US Patent No. 5,164,388, to Abbott Laboratories, 1991.
-
-
-
De, B.1
Zydowsky, T.N.2
Baker, W.R.3
Dellaria, J.F.4
Rosenberg, S.H.5
Jae, H.S.6
-
245
-
-
0036172092
-
Insights into the selective inhibition of Candida albicans secreted aspartyl protease: A Docking Analysis Study
-
DOI 10.1016/S0968-0896(01)00385-6, PII S0968089601003856
-
Pranav Kumar, S.K.; Kulkarni, V.M. Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study. Bioorg. Med. Chem., 2002, 10, 1153-1170. (Pubitemid 34139931)
-
(2002)
Bioorganic and Medicinal Chemistry
, vol.10
, Issue.4
, pp. 1153-1170
-
-
Pranav Kumar, S.K.1
Kulkarni, V.M.2
-
246
-
-
0027738942
-
Crystallization of inhibited aspartic proteinase from Candida albicans
-
DOI 10.1006/jmbi.1993.1679
-
Cutfield, S.; Marshall, C.; Moody, P.; Sullivan, P.; Cutfield, J. Crystallization of inhibited aspartic proteinase from Candida albicans. J. Mol. Biol., 1993, 234, 1266-1269. (Pubitemid 24027256)
-
(1993)
Journal of Molecular Biology
, vol.234
, Issue.4
, pp. 1266-1269
-
-
Cutfield, S.1
Marshall, C.2
Moody, P.3
Sullivan, P.4
Cutfield, J.5
-
247
-
-
34447525518
-
The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A
-
DOI 10.1002/prot.21425
-
Borelli, C.; Ruge, E.; Schaller, M.; Monod, M.; Korting, H.C.; Huber, R.; Maskos, K. The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A. Proteins, 2007, 68, 738- 748. (Pubitemid 47068312)
-
(2007)
Proteins: Structure, Function and Genetics
, vol.68
, Issue.3
, pp. 738-748
-
-
Borelli, C.1
Ruge, E.2
Schaller, M.3
Monod, M.4
Korting, H.C.5
Huber, R.6
Maskos, K.7
-
248
-
-
51349144006
-
X-ray structures of Sap1 and Sap5: Structural comparison of the secreted aspartic proteinases from
-
Borelli, C.; Ruge, E.; Lee, J.H.; Schaller, M.; Vogelsang, A.; Monod, M.; Korting, H.C.; Huber, R.; Maskos, K. X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins, 2008, 72, 1308-1319.
-
(2008)
Candida Albicans. Proteins
, vol.72
, pp. 1308-1319
-
-
Borelli, C.1
Ruge, E.2
Lee, J.H.3
Schaller, M.4
Vogelsang, A.5
Monod, M.6
Korting, H.C.7
Huber, R.8
Maskos, K.9
-
249
-
-
77950327388
-
Candida spp. bloodstream infection: Influence of antifungal treatment on outcome
-
Ortega, M.; Marco, F.; Soriano, A.; Almela, M.; Martínez, J.A.; Pitart, C.; Mensa, J. Candida spp. bloodstream infection: influence of antifungal treatment on outcome. J. Antimicrob. Chemother., 2010, 65, 562-568.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 562-568
-
-
Ortega, M.1
Marco, F.2
Soriano, A.3
Almela, M.4
Martínez, J.A.5
Pitart, C.6
Mensa, J.7
-
250
-
-
79961001586
-
Aspartic proteases of human pathogenic fungi are prospective targets for the generation of novel and effective antifungal inhibitors
-
in press
-
Santos, A.L.S. Aspartic proteases of human pathogenic fungi are prospective targets for the generation of novel and effective antifungal inhibitors. Curr. Enz. Inhib., 2011, in press.
-
(2011)
Curr. Enz. Inhib.
-
-
Santos, A.L.S.1
-
251
-
-
0029935527
-
Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents
-
Abad-Zapatero, C.; Goldman, R.; Muchmore, S.W.; Hutchins, C.; Stewart, K.; Navaza. J.; Payne, C.D.; Ray, T.L. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents. Protein Sci., 1996, 5, 640-652. (Pubitemid 26119701)
-
(1996)
Protein Science
, vol.5
, Issue.4
, pp. 640-652
-
-
Abad-Zapatero, C.1
Goldman, R.2
Muchmore, S.W.3
Hutchins, C.4
Stewart, K.5
Navaza, J.6
Payne, C.D.7
Ray, T.L.8
-
252
-
-
0023199453
-
Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
-
DOI 10.1038/329654a0
-
Katoh, I.; Yasunuga, T.; Ikawa, Y.; Yoshinaka, Y. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature, 1987, 329, 654- 656. (Pubitemid 17140121)
-
(1987)
Nature
, vol.329
, Issue.6140
, pp. 654-656
-
-
Katoh, I.1
Yasunaga, T.2
Ikawa, Y.3
Yoshinaka, Y.4
-
253
-
-
77953725356
-
Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes
-
Janneh, O.; Bray, P.G.; Jones, E.; Wyen, C.; Chiba, P.; Back, D.J.; Khoo, S.H. Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes. J. Antimicrob. Chemother., 2010, 65, 906-916.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 906-916
-
-
Janneh, O.1
Bray, P.G.2
Jones, E.3
Wyen, C.4
Chiba, P.5
Back, D.J.6
Khoo, S.H.7
-
254
-
-
0033862324
-
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir
-
DOI 10.1097/00007691-200008000-00013
-
Hugen, P.W.; Burger, D.M.; de Graaff, M.; ter Hofstede, H.J.; Hoetelmans, R.M.; Brinkman, K.; Meenhorst, P.L.; Mulder, J.W.; Koopmans, P.P.; Hekster, Y.A. Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir. Ther. Drug Monit., 2000, 22, 437-445. (Pubitemid 30622117)
-
(2000)
Therapeutic Drug Monitoring
, vol.22
, Issue.4
, pp. 437-445
-
-
Hugen, P.W.H.1
Burger, D.M.2
Graaff, M.3
Ter Hofstede, H.J.M.4
Hoetelmans, R.M.W.5
Brinkman, K.6
Meenhorst, P.L.7
Mulder, J.W.8
Koopmans, P.P.9
Hekster, Y.A.10
-
255
-
-
0042628225
-
Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient [2]
-
DOI 10.1097/00002030-200307250-00022
-
Atzori, C.; Villani, P.; Regazzi, M.; Maruzzi, M.; Cargnel, A. Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient. AIDS, 2003, 17, 1710-1711. (Pubitemid 36951698)
-
(2003)
AIDS
, vol.17
, Issue.11
, pp. 1710-1711
-
-
Atzori, C.1
Villani, P.2
Regazzi, M.3
Maruzzi, M.4
Cargnel, A.5
-
256
-
-
0032707973
-
Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease
-
Vigouroux, C.; Gharakhanian, S.; Salhi, Y.; Nguyên, T.H.; Adda, N.; Rozenbaum, W.; Capeau, J. Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. Diabetes Metab., 1999, 25, 383-392.
-
(1999)
Diabetes Metab.
, vol.25
, pp. 383-392
-
-
Vigouroux, C.1
Gharakhanian, S.2
Salhi, Y.3
Nguyên, T.H.4
Adda, N.5
Rozenbaum, W.6
Capeau, J.7
-
257
-
-
0037350147
-
Effects of HIV protease inhibitor therapy on lipid metabolism
-
DOI 10.1016/S0163-7827(02)00046-2, PII S0163782702000462
-
Hui, D.Y. Effects of HIV protease inhibitor therapy on lipid metabolism. Prog. Lipid Res., 2003, 42, 81-92. (Pubitemid 36120430)
-
(2003)
Progress in Lipid Research
, vol.42
, Issue.2
, pp. 81-92
-
-
Hui, D.Y.1
-
258
-
-
13244265683
-
Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors
-
DOI 10.1111/j.1365-201X.2004.01383.x
-
Rudich, A,; Ben-Romano, R.; Etzion, S.; Bashan, N. Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors. Acta Physiol. Scand., 2005, 183, 75-88. (Pubitemid 40188037)
-
(2005)
Acta Physiologica Scandinavica
, vol.183
, Issue.1
, pp. 75-88
-
-
Rudich, A.1
Ben-Romano, R.2
Etzion, S.3
Bashan, N.4
-
259
-
-
65549084011
-
Risk factors for gastrointestinal adverse events in HIV treated and untreated patients
-
Hill, A.; Balkin, A. Risk factors for gastrointestinal adverse events in HIV treated and untreated patients. AIDS Rev., 2009, 11, 30-38.
-
(2009)
AIDS Rev.
, vol.11
, pp. 30-38
-
-
Hill, A.1
Balkin, A.2
-
260
-
-
3042554178
-
Peptidomimetic inhibitors of HIV protease
-
DOI 10.2174/1568026043388330
-
Randolph, J.T.; DeGoey, D.A. Peptidomimetic inhibitors of HIV protease. Curr. Top. Med. Chem., 2004, 4, 1079-1095. (Pubitemid 38854858)
-
(2004)
Current Topics in Medicinal Chemistry
, vol.4
, Issue.10
, pp. 1079-1095
-
-
Randolph, J.T.1
DeGoey, D.A.2
-
261
-
-
70349486931
-
Trailing end-point phenotype antibioticsensitive strains of Candida albicans produce different amounts of aspartyl peptidases
-
Braga-Silva, L.A.; Mesquita, D.G.; Ribeiro, M.D.; Carvalho, S.M.; Fracalanzza, S.E.; Santos, A.L.S. Trailing end-point phenotype antibioticsensitive strains of Candida albicans produce different amounts of aspartyl peptidases. Braz. J. Med. Biol. Res., 2009, 42, 765-770.
-
(2009)
Braz. J. Med. Biol. Res.
, vol.42
, pp. 765-770
-
-
Braga-Silva, L.A.1
Mesquita, D.G.2
Ribeiro, M.D.3
Carvalho, S.M.4
Fracalanzza, S.E.5
Santos, A.L.S.6
-
262
-
-
35148852587
-
Effect of suramin on the human pathogen Candida albicans: Implications on the fungal development and virulence
-
DOI 10.1111/j.1574-695X.2007.00321.x
-
Braga-Silva, L.A.; Santos, A.L.S.; Portela, M.B.; Souto-Padrón, T.; Soares, R.M.A. Effect of suramin on the human pathogen Candida albicans: implications on the fungal development and virulence. FEMS Immunol. Med. Microbiol., 2007, 51, 399-406. (Pubitemid 47547518)
-
(2007)
FEMS Immunology and Medical Microbiology
, vol.51
, Issue.2
, pp. 399-406
-
-
Braga-Silva, L.A.1
Souza Dos Santos, A.L.2
Portela, M.B.3
Souto-Padron, T.4
Soares, R.M.D.A.5
-
263
-
-
70449158340
-
A simple method for the isolation and purification of total lipids from animal tissues
-
Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 1957, 226, 497-509.
-
(1957)
J. Biol. Chem.
, vol.226
, pp. 497-509
-
-
Folch, J.1
Lees, M.2
Sloane Stanley, G.H.3
|